Jennifer Tremmel
Susan P. and Riley P. Bechtel Medical Director and Associate Professor of Medicine (Cardiovascular Medicine)
Medicine - Cardiovascular Medicine
Clinical Focus
- Interventional Cardiology
- Chronic Total Occlusions (CTOs)
- Complex PCI
- Women's Cardiovascular Disease
- Microvascular Angina
- Myocardial Bridging
- MINOCA
- SCAD
Academic Appointments
-
Associate Professor - University Medical Line, Medicine - Cardiovascular Medicine
-
Member, Cardiovascular Institute
Administrative Appointments
-
Director, CTO Program (2018 - Present)
-
Director, Radial Program (2009 - Present)
-
Medical Director, Women's Heart Health at Stanford (2007 - Present)
Professional Education
-
Fellowship: Stanford University School of Medicine (2006) CA
-
Medical Education: University of Iowa Carver College of Medicine (1998) IA
-
Residency: Dartmouth Hitchcock Medical Center (2001) NH
-
Board Certification: American Board of Internal Medicine, Interventional Cardiology (2007)
-
Board Certification: American Board of Internal Medicine, Cardiovascular Disease (2006)
-
M.D., University of Iowa, Medicine (1998)
-
S.M., Harvard University, Epidemiology (2002)
Current Research and Scholarly Interests
Dr. Jennifer Tremmel is an Interventional Cardiologist in the Division of Cardiovascular Medicine at Stanford University Medical Center. She is the Endowed Medical Director of Women’s Heart Health at Stanford and conducts research on sex differences in cardiovascular disease. Much of her work has focused on patients with angina in the absence of obstructive CAD. This includes studying endothelial dysfunction, microvascular dysfunction, and myocardial bridging in patients with stable angina, and myocardial infarction with nonobstructive coronary arteries (MINOCA) and spontaneous coronary artery dissection (SCAD) in patients with acute angina. She also was an early adopter of the transradial approach and is a national expert on the topic. More recently, she started the CTO program at Stanford and has contributed to the field by demonstrating that the radial approach and same-day discharge are readily achievable in complex PCI.
Clinical Trials
-
Efficacy of Targeted Medical Therapy in Angina and Nonobstructive Coronary Arteries
Recruiting
The goal of this clinical trial is to learn if targeted medical therapy will improve symptoms and quality of life in patients with angina and non-obstructive coronary arteries compared to placebo, after the underlying cause of the chest pain has been ascertained by coronary function testing. Participants will be treated with either medications that target the underlying cause of their chest pain or placebo for 4 weeks after a drug titration phase of 1-3 weeks. They will be asked to complete a series of questionnaires to evaluate their quality of life at the beginning and end of the study.
-
Sex Differences in Coronary Pathophysiology
Recruiting
This is a research study evaluating possible causes of chest pain (or an anginal equivalent, such as fatigue resulting in a decrease in exercise tolerance, shortness of breath, or back, shoulder, neck, or jaw pain) in people with no evidence of significant coronary artery disease on their coronary angiogram (pictures of the blood vessels in the heart). The purpose of the research study is to determine if there is diffuse atherosclerosis (plaque) not appreciated by angiography, or if the coronary endothelium (lining of the blood vessels in the heart) and/or microcirculation (small vessels in the heart that are not easily seen with an angiogram) are not functioning properly in those who have chest pain (or an anginal equivalent), but normal coronary arteries on angiography. Specifically, we are interested if these findings are more common in women than men.
-
Angiographic and Psychosocial Evaluation of Peripartum vs. Non: SCAD
Not Recruiting
This multi-site international clinical research project is a collaboration between investigators from multiple institutions in the USA, Canada, and Europe. Approximately 7 to 11 sites will participate and provide data for analysis. Clinical operations (for data collection and analysis) across sites will be managed by Stanford. The study purpose is to determine differences in clinical and imaging presentation, in-hospital management and prognosis in peripartum and non-peripartum SCAD patients.
Stanford is currently not accepting patients for this trial.
-
FAME II - Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Intervention (PCI) Plus Optimal Medical Treatment (OMT) Verses OMT
Not Recruiting
The overall purpose of the FAME II trial is to compare the clinical outcomes, safety and cost-effectiveness of FFR-guided PCI plus optimal medical treatment (OMT) versus OMT alone in patients with stable coronary artery disease.
Stanford is currently not accepting patients for this trial. For more information, please contact Maria Perlas, (650) 723 - 2094.
-
TAXUS Libertē Post Approval Study
Not Recruiting
The TAXUS Libertē Post-Approval Study is an FDA-mandated prospective, multi-center study designed to collect real-world safety and clinical outcomes in approximately 4,200 patients receiving one or more TAXUS Liberté Paclitaxel-Eluting Stents and prasugrel as part of a dual antiplatelet therapy (DAPT) drug regimen. This study will also contribute patient data to an FDA-requested and industry-sponsored research study that will evaluate the optimal duration of dual antiplatelet therapy (DAPT Study).
Stanford is currently not accepting patients for this trial. For more information, please contact Yvonne Strawa, (650) 498 - 7028.
2024-25 Courses
-
Independent Studies (5)
- Directed Reading in Medicine
MED 299 (Aut, Win, Spr, Sum) - Early Clinical Experience in Medicine
MED 280 (Aut, Win, Spr, Sum) - Graduate Research
MED 399 (Aut, Win, Spr, Sum) - Medical Scholars Research
MED 370 (Aut, Win, Spr, Sum) - Undergraduate Research
MED 199 (Aut, Win, Spr, Sum)
- Directed Reading in Medicine
All Publications
-
Usefulness of temporary pacemaker during acetylcholine provocation testing
IJC HEART & VASCULATURE
2024; 53
View details for DOI 10.1016/j.ijcha.2024.101440
View details for Web of Science ID 001253589200001
-
Usefulness of temporary pacemaker during acetylcholine provocation testing.
International journal of cardiology. Heart & vasculature
2024; 53: 101440
View details for DOI 10.1016/j.ijcha.2024.101440
View details for PubMedID 38966805
View details for PubMedCentralID PMC11222927
-
Insights From Midcareer Women in Cardiology.
Journal of the American College of Cardiology
2024; 84 (2): 219-222
View details for DOI 10.1016/j.jacc.2024.04.049
View details for PubMedID 38960517
-
A Systematic Approach to the Evaluation of the Coronary Microcirculation Using Bolus Thermodilution: CATH CMD.
Journal of the Society for Cardiovascular Angiography & Interventions
2024; 3 (7): 101934
Abstract
Coronary microvascular dysfunction (CMD) can cause myocardial ischemia in patients presenting with angina without obstructive coronary artery disease (ANOCA). Evaluating for CMD by using the thermodilution technique offers a widely accessible means of assessing microvascular resistance. Through this technique, 2 validated indices, namely coronary flow reserve and the index of microcirculatory resistance, can be computed, facilitating investigation of the coronary microcirculation. The index of microcirculatory resistance specifically estimates minimum achievable microvascular resistance within the coronary microcirculation. We aim to review the bolus thermodilution method, outlining the fundamental steps for conducting measurements and introducing an algorithmic approach (CATH CMD) to systematically evaluate the coronary microcirculation. Embracing a standardized approach, exemplified by the CATH CMD algorithm, will facilitate adoption of this technique and streamline the diagnosis of CMD.
View details for DOI 10.1016/j.jscai.2024.101934
View details for PubMedID 39131992
View details for PubMedCentralID PMC11308200
-
Determining the Cause of Coronary Vasomotor Disorders in Patients With Ischemia and Nonobstructive Coronary Arteries: Design and Rationale of the DISCOVER INOCA Prospective, Multicenter Registry.
Journal of the Society for Cardiovascular Angiography & Interventions
2024; 3 (6): 102046
Abstract
Approximately 30% to 50% of patients who are referred for diagnostic coronary angiography are found to have no obstructive coronary artery disease (CAD). Ischemia and nonobstructive coronary arteries (INOCA) is increasingly recognized and encompasses coronary microvascular dysfunction, vasospastic angina, symptomatic myocardial bridging, and other vasomotor disorders. However, the prevalence of these disorders and whether underlying atherosclerotic plaque burden and morphology affect the long-term outcomes of each physiologic phenotype is unknown.The DISCOVER INOCA registry is ongoing at 8 centers in the United States and plans to enroll 500 patients with ischemic heart disease referred for angiography undergoing coronary function testing (CFT). All participants will complete patient-reported outcome measures and undergo protocol-guided angiography, acetylcholine provocation, coronary thermodilution, and intravascular imaging. Follow-up assessments occur at 30 days, 6 months, 1 year, and annually for 5 years. The primary short-term end point is the prevalence of INOCA phenotypes based on physiology and the degree of atherosclerosis based on intravascular ultrasound or optical coherence tomography (intravascular imaging). The primary long-term end point is the incidence of major adverse cardiovascular events, defined as a composite of cardiovascular death, myocardial infarction, hospitalization for cardiovascular causes, or coronary revascularization at a follow-up of 5 years. At the time of this publication, 100 participants have been enrolled.DISCOVER INOCA is the first prospective study of INOCA patients to integrate anatomic and physiologic measures of disease and correlate them with long-term outcomes. DISCOVER INOCA will report on the prevalence of INOCA phenotypes, the safety of comprehensive invasive CFT, and the impact of testing on diagnoses and medical therapy. Symptoms and cardiovascular adverse events at long-term follow-up will be determined in patients with no obstructive CAD undergoing angiography.
View details for DOI 10.1016/j.jscai.2024.102046
View details for PubMedID 39132594
View details for PubMedCentralID PMC11308755
-
Multivessel Coronary Function Testing Increases Diagnostic Yield in Patients With Angina and Nonobstructive Coronary Arteries.
JACC. Cardiovascular interventions
2024; 17 (9): 1091-1102
Abstract
Invasive CFT is the gold standard for diagnosing coronary vasomotor dysfunction in patients with ANOCA. Most institutions recommend only testing the left coronary circulation. Therefore, it is unknown whether testing multiple coronary territories would increase diagnostic yield.The aim of this study was to evaluate the diagnostic yield of multivessel, compared with single-vessel, invasive coronary function testing (CFT) in patients with angina and nonobstructive coronary arteries (ANOCA).Multivessel CFT was systematically performed in patients with suspected ANOCA. Vasoreactivity testing was performed using acetylcholine provocation in the left (20 to 200 μg) and right (20 to 80μg) coronary arteries. A pressure-temperature sensor guidewire was used for coronary physiology assessment in all three epicardial vessels.This multicenter study included a total of 228 vessels from 80 patients (57.8 ± 11.8 years of age, 60% women). Compared with single-vessel CFT, multivessel testing resulted in more patients diagnosed with coronary vasomotor dysfunction (86.3% vs 68.8%; P = 0.0005), coronary artery spasm (60.0% vs 47.5%; P = 0.004), and CMD (62.5% vs 36.3%; P < 0.001). Coronary artery spasm (n = 48) predominated in the left coronary system (n = 38), though isolated right coronary spasm was noted in 20.8% (n = 10). Coronary microvascular dysfunction (CMD), defined by abnormal index of microcirculatory resistance and/or coronary flow reserve, was present 62.5% of the cohort (n = 50). Among the cohort with CMD, 27 patients (33.8%) had 1-vessel CMD, 15 patients (18.8%) had 2-vessel CMD, and 8 patients (10%) had 3-vessel CMD. CMD was observed at a similar rate in the territories supplied by all 3 major coronary vessels (left anterior descending coronary artery = 36.3%, left circumflex coronary artery = 33.8%, right coronary artery = 31.3%; P = 0.486).Multivessel CFT resulted in an increased diagnostic yield in patients with ANOCA compared with single-vessel testing. The results of this study suggest that multivessel CFT has a role in the management of patients with ANOCA.
View details for DOI 10.1016/j.jcin.2024.03.007
View details for PubMedID 38749588
-
Highlights From the Society for Cardiovascular Angiography & Interventions (SCAI) Scientific Sessions 2023.
Journal of the American Heart Association
2024: e031067
View details for DOI 10.1161/JAHA.123.031067
View details for PubMedID 38533981
-
Paclitaxel-Coated Balloon vs Uncoated Balloon for Coronary In-Stent Restenosis: The AGENT IDE Randomized Clinical Trial.
JAMA
2024
Abstract
Importance: Drug-coated balloons offer a potentially beneficial treatment strategy for the management of coronary in-stent restenosis. However, none have been previously evaluated or approved for use in coronary circulation in the United States.Objective: To evaluate whether a paclitaxel-coated balloon is superior to an uncoated balloon in patients with in-stent restenosis undergoing percutaneous coronary intervention.Design, Setting, and Participants: AGENT IDE, a multicenter randomized clinical trial, enrolled 600 patients with in-stent restenosis (lesion length <26 mm and reference vessel diameter >2.0 mm to ≤4.0 mm) at 40 centers across the United States between May 2021 and August 2022. One-year clinical follow-up was completed on October 2, 2023.Interventions: Participants were randomized in a 2:1 allocation to undergo treatment with a paclitaxel-coated (n=406) or an uncoated (n=194) balloon.Main Outcomes and Measures: The primary end point of 1-year target lesion failure-defined as the composite of ischemia-driven target lesion revascularization, target vessel-related myocardial infarction, or cardiac death-was tested for superiority.Results: Among 600 randomized patients (mean age, 68 years; 157 females [26.2%]; 42 Black [7%], 35 Hispanic [6%] individuals), 574 (95.7%) completed 1-year follow-up. The primary end point at 1 year occurred in 17.9% in the paclitaxel-coated balloon group vs 28.6% in the uncoated balloon group, meeting the criteria for superiority (hazard ratio [HR], 0.59 [95% CI, 0.42-0.84]; 2-sided P=.003). Target lesion revascularization (13.0% vs 24.7%; HR, 0.50 [95% CI, 0.34-0.74]; P=.001) and target vessel-related myocardial infarction (5.8% vs 11.1%; HR, 0.51 [95% CI, 0.28-0.92]; P=.02) occurred less frequently among patients treated with paclitaxel-coated balloon. The rate of cardiac death was 2.9% vs 1.6% (HR, 1.75 [95% CI, 0.49-6.28]; P=.38) in the coated vs uncoated balloon groups, respectively.Conclusions and Relevance: Among patients undergoing coronary angioplasty for in-stent restenosis, a paclitaxel-coated balloon was superior to an uncoated balloon with respect to the composite end point of target lesion failure. Paclitaxel-coated balloons are an effective treatment option for patients with coronary in-stent restenosis.Trial Registration: ClinicalTrials.gov Identifier: NCT04647253.
View details for DOI 10.1001/jama.2024.1361
View details for PubMedID 38460161
-
Coronary Microvascular Dysfunction.
Journal of the Society for Cardiovascular Angiography & Interventions
2024; 3 (3Part A): 101230
View details for DOI 10.1016/j.jscai.2023.101230
View details for PubMedID 39131786
View details for PubMedCentralID PMC11307378
-
Comprehensive Management of ANOCA, Part 2-Program Development, Treatment, and Research Initiatives: JACC State-of-the-Art Review.
Journal of the American College of Cardiology
2023; 82 (12): 1264-1279
Abstract
Centers specializing in coronary function testing are critical to ensure a systematic approach to the diagnosis and treatment of angina with nonobstructive coronary arteries (ANOCA). Management leveraging lifestyle, pharmacology, and device-based therapeutic options for ANOCA can improve angina burden and quality of life in affected patients. Multidisciplinary care teams that can tailor and titrate therapies based on individual patient needs are critical to the success of comprehensive programs. As coronary function testing for ANOCA is more widely adopted, collaborative research initiatives will be fundamental to improve ANOCA care. These efforts will require standardized symptom assessments and data collection, which will propel future large-scale clinical trials.
View details for DOI 10.1016/j.jacc.2023.06.044
View details for PubMedID 37704316
-
Comprehensive Management of ANOCA, Part 1-Definition, Patient Population, and Diagnosis: JACC State-of-the-Art Review.
Journal of the American College of Cardiology
2023; 82 (12): 1245-1263
Abstract
Angina with nonobstructive coronary arteries (ANOCA) is increasingly recognized and may affect nearly one-half of patients undergoing invasive coronary angiography for suspected ischemic heart disease. This working diagnosis encompasses coronary microvascular dysfunction, microvascular and epicardial spasm, myocardial bridging, and other occult coronary abnormalities. Patients with ANOCA often face a high burden of symptoms and may experience repeated presentations to multiple medical providers before receiving a diagnosis. Given the challenges of establishing a diagnosis, patients with ANOCA frequently experience invalidation and recidivism, possibly leading to anxiety and depression. Advances in scientific knowledge and diagnostic testing now allow for routine evaluation of ANOCA noninvasively and in the cardiac catheterization laboratory with coronary function testing (CFT). CFT includes diagnostic coronary angiography, assessment of coronary flow reserve and microcirculatory resistance, provocative testing for endothelial dysfunction and coronary vasospasm, and intravascular imaging for identification of myocardial bridging, with hemodynamic assessment as needed.
View details for DOI 10.1016/j.jacc.2023.06.043
View details for PubMedID 37704315
-
Prevention of Cardiovascular Disease in Women With Pregnancy-Related Risk Factors: A Prospective Women's Heart Clinic Study.
Journal of the American Heart Association
2023: e030015
Abstract
Background Hypertensive disorders of pregnancy, gestational diabetes, and having a small-for-gestational-age baby are known to substantially increase a woman's risk of cardiovascular disease. Despite this, evidence for models of care that mitigate cardiovascular disease risk in women with these pregnancy-related conditions is lacking. Methods and Results A 6-month prospective cohort study assessed the effectiveness of a multidisciplinary Women's Heart Clinic on blood pressure and lipid control in women aged 30 to 55 years with a past pregnancy diagnosis of hypertensive disorders of pregnancy, gestational diabetes, or a small-for-gestational age baby in Melbourne, Australia. The co-primary end points were (1) blood pressure <140/90 mm Hg or <130/80 mm Hg if diabetes and (2) total cholesterol to high-density lipoprotein cholesterol ratio <4.5. The study recruited 156 women with a mean age of 41.0±4.2 years, 3.9±2.9 years from last delivery, 68.6% White, 20.5% South/East Asian, and 80.5% university-educated. The proportion meeting blood pressure target increased (69.2% to 80.5%, P=0.004), with no significant change in lipid targets (80.6% to 83.7%, P=0.182). Systolic blood pressure (-6.9 mm Hg [95% CI, -9.1 to -4.7], P<0.001), body mass index (-0.6 kg/m2 [95% CI, -0.8 to -0.3], P<0.001), low-density lipoprotein cholesterol (-4.2 mg/dL [95% CI, -8.2 to -0.2], P=0.042), and total cholesterol (-4.6 mg/dL [95% CI, -9.1 to -0.2] P=0.042) reduced. Heart-healthy lifestyle significantly improved with increased fish/olive oil (36.5% to 51.0%, P=0.012), decreased fast food consumption (33.8% to 11.0%, P<0.001), and increased physical activity (84.0% to 92.9%, P=0.025). Conclusions Women at high risk for cardiovascular disease due to past pregnancy-related conditions experienced significant improvements in multiple cardiovascular risk factors after attending a Women's Heart Clinic, potentially improving long-term cardiovascular disease outcomes. Registration URL: https://www.anzctr.org.au; Unique identifier: ACTRN12622000646741.
View details for DOI 10.1161/JAHA.123.030015
View details for PubMedID 37642017
-
2023 ACC/AHA/SCAI Advanced Training Statement on Interventional Cardiology (Coronary, Peripheral Vascular, and Structural Heart Interventions)
JACC-CARDIOVASCULAR INTERVENTIONS
2023; 16 (10): 1239-1291
View details for DOI 10.1016/j.jcin.2023.04.011
View details for Web of Science ID 001011279100001
-
Impact of myocardial bridging on coronary artery plaque formation and long-term mortality after heart transplantation.
International journal of cardiology
2023
Abstract
OBJECTIVES: This study aimed to explore the impact of myocardial bridging (MB) on early development of cardiac allograft vasculopathy and long-term graft survival after heart transplantation.BACKGROUND: MB has been reported to be associated with acceleration of proximal plaque development and endothelial dysfunction in native coronary atherosclerosis. However, its clinical significance in heart transplantation remains unclear.METHODS: In 103 heart-transplant recipients, serial (baseline and 1-year post-transplant) volumetric intravascular ultrasound (IVUS) analyses were performed in the first 50 mm of the left anterior descending (LAD) artery. Standard IVUS indices were evaluated in 3 equally divided LAD segments (proximal, middle, and distal segments). MB was defined by IVUS as an echolucent muscular band lying on top of the artery. The primary endpoint was death or re-transplantation, assessed for up to 12.2 years (median follow-up: 4.7 years).RESULTS: IVUS identified MB in 62% of the study population. At baseline, MB patients had smaller intimal volume in the distal LAD than non-MB patients (p = 0.002). During the first year, vessel volume decreased diffusely irrespective of the presence of MB. Intimal growth diffusely distributed in non-MB patients, whereas MB patients demonstrated significantly augmented intimal formation in the proximal LAD. Kaplan-Meier analysis revealed significantly lower event-free survival in patients with versus without MB (log-rank p = 0.02). In multivariate analysis, the presence of MB was independently associated with late adverse events [hazard ratio 5.1 (1.6-22.2)].CONCLUSION: MB appears to relate to accelerated proximal intimal growth and reduced long-term survival in heart-transplant recipients.
View details for DOI 10.1016/j.ijcard.2023.03.014
View details for PubMedID 36893856
-
2023 ACC/AHA/SCAI Advanced Training Statement on Interventional Cardiology (Coronary, Peripheral Vascular, and Structural Heart Interventions): A Report of the ACC Competency Management Committee.
Circulation. Cardiovascular interventions
2023: e000088
View details for DOI 10.1161/HCV.0000000000000088
View details for PubMedID 36795800
-
2023 ACC/AHA/SCAI Advanced Training Statement on Interventional Cardiology (Coronary, Peripheral Vascular, and Structural Heart Interventions): A Report of the ACC Competency Management Committee.
Journal of the American College of Cardiology
2023
View details for DOI 10.1016/j.jacc.2022.11.002
View details for PubMedID 36801119
-
Symptomatic Myocardial Bridging in D-Transposition of the Great Arteries Post-Arterial Switch
JACC: Case Reports, Vol 8, Iss , Pp 101730- (2023)
2023
View details for DOI 10.1016/j.jaccas.2022.101730
-
Safety of Provocative Testing With Intracoronary Acetylcholine and Implications for Standard Protocols.
Journal of the American College of Cardiology
2022; 79 (24): 2367-2378
Abstract
BACKGROUND: Heterogeneity in diagnostic criteria and provocation protocols has posed challenges in understanding the safety of coronary provocation testing with intracoronary acetylcholine (ACh) for the contemporary diagnosis of epicardial and microvascular spasm.OBJECTIVES: We examined the safety of testing and subgroup differences in procedural risks based on ethnicity, diagnostic criteria, and provocation protocols.METHODS: PubMed and Embase were searched in November 2021 to identify original articles reporting procedural complications associated with intracoronary ACh administration. The primary outcome was the pooled estimate of the incidence of major complications including death, myocardial infarction, ventricular tachycardia/fibrillation, and shock.RESULTS: A total of 16 studies with 12,585 patients were included in the meta-analysis. The overall pooled estimate of the incidence of major complications was 0.5% (95%CI: 0.0%-1.3%) without any reports of death. Exploratory subgroup analyses revealed that the pooled incidence of major complications was significantly higher in the studies that followed the contemporary diagnosis criteria for epicardial spasm defined as≥90% diameter reduction (1.0%; 95%CI: 0.3%-2.0%) but significantly lower in Western populations (0.0%; 95%CI: 0.0%-0.45%). The rate of positive epicardial spasm and the incidence of major complications were similar between provocation protocols using the maximum ACh doses of 100mug and 200mug.CONCLUSIONS: Intracoronary ACh administration for the contemporary diagnosis of epicardial and microvascular spasm is a safe procedure. Moreover, excellent safety records are observed in Western populations primarily presenting with myocardial ischemia and/or infarction with nonobstructive coronary arteries. This study will help standardize ACh testing to improve clinical diagnosis and ensure procedural safety.
View details for DOI 10.1016/j.jacc.2022.03.385
View details for PubMedID 35710187
-
Implications of the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Chest Pain Guideline for Cardiovascular Imaging: A Multisociety Viewpoint.
JACC. Cardiovascular imaging
2022; 15 (5): 912-926
View details for DOI 10.1016/j.jcmg.2022.02.021
View details for PubMedID 35512960
-
The 2021 AHA/ACC Guideline for the Evaluation and Diagnosis of Chest Pain: An Interventionalist's Viewpoint.
Journal of the Society for Cardiovascular Angiography & Interventions
2022; 1 (3): 100305
View details for DOI 10.1016/j.jscai.2022.100305
View details for PubMedID 39131964
View details for PubMedCentralID PMC11308083
-
Colocalization of Coronary Plaque with Wall Shear Stress in Myocardial Bridge Patients.
Cardiovascular engineering and technology
2022
Abstract
PURPOSE: Patients with myocardial bridges (MBs) have a higher prevalence of atherosclerosis. Wall shear stress (WSS) has previously been correlated with plaque in coronary artery disease patients, but such correlations have not been investigated in symptomatic MB patients. The aim of this paper was to use a multi-scale computational fluid dynamics (CFD) framework to simulate hemodynamics in MB patient, and investigate the co-localization of WSS and plaque.METHODS: We identified N = 10 patients from a previously reported cohort of 50 symptomatic MB patients, all of whom had plaque in the proximal vessel. Dynamic 3D models were reconstructed from coronary computed tomography angiography (CCTA), intravascular ultrasound (IVUS) and catheter angiograms. CFD simulations were performed to compute WSS proximal to, within and distal to the MB. Plaque was quantified from IVUS images in 2 mm segments and registered to CFD model. Plaque area was compared to absolute and patient-normalized WSS.RESULTS: WSS was lower in the proximal segment compared to the bridge segment (6.1 ± 2.9 vs. 16.0 ± 7.1 dynes/cm2, p value < 0.01). Plaque area and plaque burden measured from IVUS peaked at 1-3 cm proximal to the MB entrance, coinciding with the first diagonal branch. Normalized WSS showed a statistically significant moderate correlation with plaque area (r = 0.41, p < 0.01).CONCLUSION: WSS may be obtained non-invasively in MB patients and provides a surrogate marker of plaque area. Using CFD, it may be possible to non-invasively assess the extent of plaque area, and identify patients who could benefit from frequent monitoring or medical management.
View details for DOI 10.1007/s13239-022-00616-4
View details for PubMedID 35296987
-
SCAI Expert Consensus Statement on Sex-Specific Considerations in Myocardial Revascularization.
Journal of the Society for Cardiovascular Angiography & Interventions
2022; 1 (2): 100016
View details for DOI 10.1016/j.jscai.2021.100016
View details for PubMedID 39132570
View details for PubMedCentralID PMC11307953
-
Association of Neighborhood Income with Clinical Outcomes Among Pregnant Patients with Cardiac Disease
Reproductive Sciences
2022
View details for DOI 10.1007/s43032-022-00978-z
- SCAI Expert Consensus Statement on Sex-Specific Considerations in Myocardial Revascularization Journal of the Society for Cardiovascular Angiography & Interventions 2022; 1 (2)
-
Relationship Between Coronary Atheroma, Epicardial Adipose Tissue Inflammation, and Adipocyte Differentiation Across the Human Myocardial Bridge.
Journal of the American Heart Association
2021: e021003
Abstract
Background Inflammation in epicardial adipose tissue (EAT) may contribute to coronary atherosclerosis. Myocardial bridge is a congenital anomaly in which the left anterior descending coronary artery takes a "tunneled" course under a bridge of myocardium: while atherosclerosis develops in the proximal left anterior descending coronary artery, the bridged portion is spared, highlighting the possibility that geographic separation from inflamed EAT is protective. We tested the hypothesis that inflammation in EAT was related to atherosclerosis by comparing EAT from proximal and bridge depots in individuals with myocardial bridge and varying degrees of atherosclerotic plaque. Methods and Results Maximal plaque burden was quantified by intravascular ultrasound, and inflammation was quantified by pericoronary EAT signal attenuation (pericoronary adipose tissue attenuation) from cardiac computed tomography scans. EAT overlying the proximal left anterior descending coronary artery and myocardial bridge was harvested for measurement of mRNA and microRNA (miRNA) using custom chips by Nanostring; inflammatory cytokines were measured in tissue culture supernatants. Pericoronary adipose tissue attenuation was increased, indicating inflammation, in proximal versus bridge EAT, in proportion to atherosclerotic plaque. Individuals with moderate-high versus low plaque burden exhibited greater expression of inflammation and hypoxia genes, and lower expression of adipogenesis genes. Comparison of gene expression in proximal versus bridge depots revealed differences only in participants with moderate-high plaque: inflammation was higher in proximal and adipogenesis lower in bridge EAT. Secreted inflammatory cytokines tended to be higher in proximal EAT. Hypoxia-inducible factor 1a was highly associated with inflammatory gene expression. Seven miRNAs were differentially expressed by depot: 3192-5P, 518D-3P, and 532-5P were upregulated in proximal EAT, whereas miR 630, 575, 16-5P, and 320E were upregulated in bridge EAT. miR 630 correlated directly with plaque burden and inversely with adipogenesis genes. miR 3192-5P, 518D-3P, and 532-5P correlated inversely with hypoxia/oxidative stress, peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PCG1a), adipogenesis, and angiogenesis genes. Conclusions Inflammation is specifically elevated in EAT overlying atherosclerotic plaque, suggesting that EAT inflammation is caused by atherogenic molecular signals, including hypoxia-inducible factor 1a and/or miRNAs in an "inside-to-out" relationship. Adipogenesis was suppressed in the bridge EAT, but only in the presence of atherosclerotic plaque, supporting cross talk between the vasculature and EAT. miR 630 in EAT, expressed differentially according to burden of atherosclerotic plaque, and 3 other miRNAs appear to inhibit key genes related to adipogenesis, angiogenesis, hypoxia/oxidative stress, and thermogenesis in EAT, highlighting a role for miRNA in mediating cross talk between the coronary vasculature and EAT.
View details for DOI 10.1161/JAHA.121.021003
View details for PubMedID 34726081
-
Impact of Diastolic Vessel Restriction on Quality of Life in Symptomatic Myocardial Bridging Patients Treated With Surgical Unroofing: Preoperative Assessments With Intravascular Ultrasound and Coronary Computed Tomography Angiography.
Circulation. Cardiovascular interventions
2021; 14 (10): e011062
Abstract
[Figure: see text].
View details for DOI 10.1161/CIRCINTERVENTIONS.121.011062
View details for PubMedID 34665656
-
Global Chronic Total Occlusion CrossingAlgorithm: JACC State-of-the-Art Review.
Journal of the American College of Cardiology
2021; 78 (8): 840-853
Abstract
The authors developed a global chronic total occlusion crossing algorithm following 10 steps: 1) dual angiography; 2) careful angiographic review focusing on proximal cap morphology, occlusion segment, distal vessel quality, and collateral circulation; 3) approaching proximal cap ambiguity using intravascular ultrasound, retrograde, and move-the-cap techniques; 4) approaching poor distal vessel quality using the retrograde approach and bifurcation at the distal cap by use of a dual-lumen catheter and intravascular ultrasound; 5) feasibility of retrograde crossing through grafts and septal and epicardial collateral vessels; 6) antegrade wiring strategies; 7) retrograde approach; 8) changing strategy when failing to achieve progress; 9) considering performing an investment procedure if crossing attempts fail; and 10) stopping when reaching high radiation or contrast dose or in case of long procedural time, occurrence of a serious complication, operator and patient fatigue, or lack of expertise or equipment. This algorithm can improve outcomes and expand discussion, research, and collaboration.
View details for DOI 10.1016/j.jacc.2021.05.055
View details for PubMedID 34412818
-
Abnormal shear stress and residence time are associated with proximal coronary atheroma in the presence of myocardial bridging.
International journal of cardiology
2021
Abstract
BACKGROUND: Atheromatous plaques tend to form in the coronary segments proximal to a myocardial bridge (MB), but the mechanism of this occurrence remains unclear. This study evaluates the relationship between blood flow perturbations and plaque formation in patients with an MB.METHODS AND RESULTS: A total of 92 patients with an MB in the mid left anterior descending artery (LAD) and 20 patients without an MB were included. Coronary angiography, intravascular ultrasound, and coronary physiology measurements were performed. A moving-boundary computational fluid dynamics algorithm was used to derive wall shear stress (WSS) and peak residence time (PRT). Patients with an MB had lower WSS (0.46 ± 0.21 vs. 0.96 ± 0.33 Pa, p < 0.001) and higher maximal plaque burden (33.6 ± 15.0 vs. 14.2 ± 5.8%, p < 0.001) within the proximal LAD compared to those without. Plaque burden in the proximal LAD correlated significantly with proximal WSS (r = -0.51, p < 0.001) and PRT (r = 0.60, p < 0.001). In patients with an MB, the site of maximal plaque burden occurred 23.4 ± 13.3 mm proximal to the entrance of the MB, corresponding to the site of PRT.CONCLUSIONS: Regions of low WSS and high PRT occur in arterial segments proximal to an MB, and this is associated with the degree and location of coronary atheroma formation.
View details for DOI 10.1016/j.ijcard.2021.08.011
View details for PubMedID 34375705
-
Rationale and Design of a Randomized Study Comparing the Agent Drug Coated Balloon to Plain Old Balloon Angioplasty in Patients with In-Stent Restenosis.
American heart journal
2021
Abstract
BACKGROUND: Drug-coated balloon (DCB) technology was developed as an alternative treatment for obstructive coronary artery disease (CAD) and in-stent restenosis (ISR). Management of coronary ISR is clinically challenging and frequently encountered in practice. The Agent DCB uses an inactive excipient to effectively deliver a targeted, therapeutic dose of paclitaxel to the vessel wall.STUDY DESIGN: AGENT IDE is a prospective, multicenter, randomized controlled trial to evaluate superiority of the Agent DCB to balloon angioplasty in treating patients with ISR. A total of 480 patients with ISR of a previously treated lesion length <26 mm and reference vessel diameter >2.0 mm to ≤4.0 mm will be initially randomized. Subjects presenting with recent myocardial infarction (MI), complex lesions, or thrombus in the target vessel will be excluded. An adaptive group sequential design with one formal interim analysis for sample size re-estimation will be conducted, and the sample size may be increased to a maximum of 600 subjects. The primary endpoint is the rate of 12-month target lesion failure (TLF; composite of any ischemia-driven revascularization of the target lesion (TLR), target vessel related MI, or cardiac death) and will be tested for superiority in the test arm against the control. Functional status and general health-related quality of life will be measured by changes in the EQ-5D scores. Subjects will be followed for 5 years following the index procedure.CONCLUSION: This study will prospectively evaluate the safety and efficacy of Agent DCB in patients treated for coronary ISR.
View details for DOI 10.1016/j.ahj.2021.07.008
View details for PubMedID 34314727
-
Preliminary Support for Group Cognitive Behavioral Therapy (CBT) to Reduce Psychological Distress in Patients with Spontaneous Coronary Artery Dissection (SCAD).
Journal of clinical psychology in medical settings
2021
Abstract
Spontaneous coronary artery dissection (SCAD) can occur as an atypical cause of myocardial infarction. Preliminary evidence suggests that SCAD patients experience high rates of post-event psychological distress. It is unknown whether psychosocial interventions may reduce the distress burden. Seven SCAD patients (mean age=53.3years) completed a CBT-based support group. All seven participants completed measures for anxiety, depression, and cardiac-related quality of life at baseline and post-intervention, and five participants completed measures at 3-month follow-up. Six of 7 participants scored above the clinical threshold on a measure of anxiety at baseline and posttreatment. At follow-up, 3 of 5 participants scored below the clinical threshold. For depression, 3 of 7 reported elevated depressive symptoms at baseline. By follow-up, 1 of 5 endorsed elevated depressive symptoms. This is the first known psychosocial intervention study of patients with SCAD. Anxiety symptoms improved for most patients by follow-up with some patients having improved depressive symptoms. Although the sample size is limited, this pilot study suggests a potential benefit of group psychosocial interventions for SCAD survivors.
View details for DOI 10.1007/s10880-021-09803-2
View details for PubMedID 34241761
-
IMPACT OF DIASTOLIC VESSEL RESTRICTION ON CLINICAL SYMPTOMS IN PATIENTS WITH SYMPTOMATIC MYOCARDIAL BRIDGING
ELSEVIER SCIENCE INC. 2021: 165
View details for Web of Science ID 000647487500165
-
TWEET4WELLNESS: PILOT FOR A TWITTER-BASED SUPPORT GROUP WITH DAILY THEORY-BASED STRATEGIES TO DECREASE SEDENTARY BEHAVIOR.
OXFORD UNIV PRESS INC. 2021: S484
View details for Web of Science ID 000648922701173
-
Perforation Mechanisms, Risk Stratification, and Management in the Non-post Coronary Artery Bypass Graft Patient.
Interventional cardiology clinics
2021; 10 (1): 93–99
View details for DOI 10.1016/j.iccl.2020.09.005
View details for PubMedID 33223111
-
Invasive Assessment of Myocardial Bridging in Patients with Angina and No Obstructive Coronary Artery Disease.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
2020
Abstract
AIMS: Angina and no obstructive CAD (ANOCA) is common. A potential cause of angina in this patient population is a myocardial bridge (MB). We studied the anatomical and hemodynamic characteristics of an MB in patients with angina and no obstructive CAD.METHODS AND RESULTS: Using intravascular ultrasound (IVUS), we identified 184 MBs in 154 patients. We evaluated MB length, arterial compression, and halo thickness. MB muscle index (MMI) was defined as MB length*halo thickness. Hemodynamic testing of the MB was performed using an intracoronary pressure/Doppler flow wire at rest and during dobutamine stress. We defined an abnormal diastolic fractional flow reserve (dFFR) as ≤0.76 during stress. The median MB length was 22.9 mm, arterial compression 30.9%, and halo thickness 0.5mm. The median MMI was 12.1. Endothelial and microvascular dysfunction were present in 85.4% and 22.1%, respectively. At peak dobutamine stress, 94.2% of patients had a dFFR≤0.76 within and/or distal to the MB. MMI was associated with an abnormal dFFR.CONCLUSIONS: In select patients with ANOCA who have an MB by IVUS, a majority have evidence of a hemodynamically significant dFFR during dobutamine stress, suggesting the MB as a cause of their angina. A comprehensive invasive assessment of such patients during coronary angiography provides important diagnostic information that can guide management.
View details for DOI 10.4244/EIJ-D-20-00779
View details for PubMedID 33074153
-
Effect of ranolazine on symptom and quality of life in patients with angina in the absence of obstructive coronary artery disease: A case control study
INTERNATIONAL JOURNAL OF CARDIOLOGY
2020; 309: 8–13
View details for Web of Science ID 000531868300003
-
SCAI Position Statement on Optimal Percutaneous Coronary Interventional Therapy for Complex Coronary Artery Disease.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
2020
View details for DOI 10.1002/ccd.28994
View details for PubMedID 32406991
-
Dose-Response Relationship Between Intracoronary Acetylcholine and Minimal Lumen Diameter in Coronary Endothelial Function Testing of Women and Men With Angina and No Obstructive Coronary Artery Disease.
Circulation. Cardiovascular interventions
2020; 13 (4): e008587
Abstract
BACKGROUND: Intracoronary acetylcholine (Ach) provocation testing is the gold standard for assessing coronary endothelial function. However, dosing regimens of Ach are quite varied in the literature, and there are limited data evaluating the optimal dose. We evaluated the dose-response relationship between Ach and minimal lumen diameter (MLD) by sex and studied whether incremental intracoronary Ach doses given during endothelial function testing improve its diagnostic utility.METHODS: We evaluated 65 men and 212 women with angina and no obstructive coronary artery disease who underwent endothelial function testing using the highest tolerable dose of intracoronary Ach, up to 200 mug. Epicardial endothelial dysfunction was defined as a decrease in MLD >20% after intracoronary Ach by quantitative coronary angiography. We used a linear mixed effects model to evaluate the dose-response relationship. Deming regression analysis was done to compare the %MLD constriction after incremental doses of intracoronary Ach.RESULTS: The mean age was 53.5 years. Endothelial dysfunction was present in 186 (68.1%). Among men with endothelial dysfunction, there was a significant decrease in MLD/10 g of Ach at doses above 50 mug and 100 g, while this decrease in MLD was not observed in women (P<0.001). The %MLD constriction at 20 mug versus 50 mug and 50 mug versus 100 mug were not equivalent while the %MLD constriction at 100 mug versus 200 mug were equivalent.CONCLUSIONS: Women and men appear to have different responses to Ach during endothelial function testing. In addition to having a greater response to intracoronary Ach at all doses, men also demonstrate an Ach-MLD dose-response relationship with doses up to 200 mug, while women have minimal change in MLD with doses above 50 g. An incremental dosing regimen during endothelial function testing appears to improve the diagnostic utility of the test and should be adjusted based on the sex of the patient.
View details for DOI 10.1161/CIRCINTERVENTIONS.119.008587
View details for PubMedID 32279562
-
Effect of ranolazine on symptom and quality of life in patients with angina in the absence of obstructive coronary artery disease: A case control study.
International journal of cardiology
2020
Abstract
BACKGROUND: More than 20% of patients presenting to the catheterization lab have no significant obstructive coronary artery disease (CAD) despite having angina. Several occult coronary abnormalities, including endothelial dysfunction, microvascular dysfunction (MVD), and/or a myocardial bridge (MB), may explain their symptoms. We studied the effect of ranolazine on symptoms and quality of life (QOL) in these patients.METHODS: We retrospectively studied 53 patients prescribed with ranolazine, matched on sex and age, with 106 patients on standard of care who underwent comprehensive invasive testing. Endothelial dysfunction was defined as a decrease in luminal diameter of >20% after intracoronary acetylcholine, MVD as an index of microvascular resistance ≥25, and a MB as an echolucent half-moon sign and/or ≥10% systolic compression on intravascular ultrasound. A Seattle Angina Questionnaire (SAQ) and SF-12 questionnaire were completed at baseline and follow-up.RESULTS: Median follow-up was 1.9 (1.7-2.2) years. Endothelial dysfunction was present in 109 (69%), MVD in 36 (23%), and an MB in 86 (54%). Both groups had significant improvement in all dimensions of the SF-12 and SAQ with the exception of treatment satisfaction. We found no significant difference in change in SAQ and SF-12 scores between the groups, although the ranolazine group had significantly lower baseline SAQ scores.CONCLUSION: In patients with angina and no obstructive CAD, ranolazine is no different than standard of care in symptomatic and QOL improvement. Further randomized trials are warrented to confirm our findings and identify novel medical therapies in this patient population.
View details for DOI 10.1016/j.ijcard.2020.02.014
View details for PubMedID 32220488
-
Accuracy of a novel stress echocardiography pattern for myocardial bridging in patients with angina and no obstructive coronary artery disease - A retrospective and prospective cohort study.
International journal of cardiology
2020
Abstract
BACKGROUND: Myocardial bridge (MB) may cause angina in patients with no obstructive coronary artery disease (CAD). We previously reported a novel stress echocardiography (SE) pattern of focal septal buckling with apical sparing in the end-systolic to early-diastolic phase that is associated with the presence of an MB. We evaluated the diagnostic accuracy of this pattern, and prospectively validated our results.METHODS: The retrospective cohort included 158 patients with angina who underwent both SE and coronary CT angiography (CCTA). The validation cohort included 37 patients who underwent CCTA in the emergency department for angina, and prospectively underwent SE. CCTA was used as a reference standard for the presence/absence of an MB, and also confirmed no obstructive CAD.RESULTS: In the retrospective cohort, an MB was present in 107 (67.7%). The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were 91.6%, 70.6%, 86.7% and 80%, respectively. On logistic regression, focal septal buckling and Duke treadmill score were associated with an MB. In the validation cohort, an MB was present in 31 (84%). The sensitivity, specificity PPV and NPV were 90.3%, 83.3%, 96.5% and 62.5%, respectively. On logistic regression, focal septal buckling was associated with an MB.CONCLUSION: Presence of focal septal buckling with apical sparing on SE is an accurate predictor of an MB in patients with angina and no obstructive CAD. This pattern can reliably be used to screen patients who may benefit from advanced non-invasive/invasive testing for an MB as a cause of their angina.
View details for DOI 10.1016/j.ijcard.2020.02.006
View details for PubMedID 32145938
-
Sex Differences in Non-Obstructive Coronary Artery Disease.
Cardiovascular research
2020
Abstract
Ischemic heart disease is a leading cause of morbidity and mortality in both women and men. Compared to men, symptomatic women who are suspected of having myocardial ischemia are more likely to have no obstructive coronary artery disease (CAD) on coronary angiography. Coronary vasomotor disorders and coronary microvascular dysfunction (CMD) have been increasingly recognized as important contributors to angina and adverse outcomes in patients with no obstructive CAD. CMD from functional and structural abnormalities in the microvasculature is associated with adverse cardiac events and mortality in both sexes. Women may be particularly susceptible to vasomotor disorders and CMD due to unique factors such as inflammation, mental stress, autonomic and neuro-endocrine dysfunction, which predispose to endothelial dysfunction and CMD. CMD can be detected with coronary reactivity testing and non-invasive imaging modalities; however, it remains underdiagnosed. This review focuses on sex differences in presentation, pathophysiologic risk factors, diagnostic testing, and prognosis of CMD.
View details for DOI 10.1093/cvr/cvaa001
View details for PubMedID 31958135
-
Twitter-Based Social Support Added to Fitbit Self-Monitoring for Decreasing Sedentary Behavior: Protocol for a Randomized Controlled Pilot Trial With Female Patients From a Women's Heart Clinic.
JMIR research protocols
2020; 9 (12): e20926
Abstract
Prolonged sitting is an independent risk behavior for the development of chronic disease. With most interventions focusing on physical activity and exercise, there is a separate need for investigation into innovative and accessible interventions to decrease sedentary behavior throughout the day. Twitter is a social media platform with application for health communications and fostering of social support for health behavior change.This pilot study aims to test the feasibility, acceptability, and preliminary efficacy of delivering daily behavior change strategies within private Twitter groups to foster peer-to-peer support and decrease sedentary behavior throughout the day in women. The Twitter group was combined with a Fitbit for self-monitoring activity and compared to a Fitbit-only control group.In a 2-group design, participants were randomized to a Twitter + Fitbit treatment group or a Fitbit-only control group. Participants were recruited via the Stanford Research Repository System, screened for eligibility, and then invited to an orientation session. After providing informed consent, they were randomized. All participants received 13 weeks of tailored weekly step goals and a Fitbit. The treatment group participants, placed in a private Twitter support group, received daily automated behavior change "tweets" informed by theory and regular automated encouragement via text to communicate with the group. Fitbit data were collected daily throughout the treatment and follow-up period. Web-based surveys and accelerometer data were collected at baseline, treatment end (13 weeks), and at 8.5 weeks after the treatment.The initial study design funding was obtained from the Women's Heart Clinic and the Stanford Clayman Institute. Funding to run this pilot study was received from the National Institutes of Health's National Heart, Lung, and Blood Institute under Award Number K01HL136702. All procedures were approved by Stanford University's Institutional Review Board, #32127 in 2018, prior to beginning data collection. Recruitment for this study was conducted in May 2019. Of the 858 people screened, 113 met the eligibility criteria, 68 came to an information session, and 45 consented to participate in this pilot study. One participant dropped out of the intervention, and complete follow-up data were obtained from 39 of the 45 participants (87% of the sample). Data were collected over 6 months from June to December 2019. Feasibility, acceptability, and preliminary efficacy results are being analyzed and will be reported in the winter of 2021.This pilot study is assessing the feasibility, acceptability, and preliminary efficacy of delivering behavior change strategies in a Twitter social support group to decrease sedentary behavior in women. These findings will inform a larger evaluation. With an accessible, tailorable, and flexible platform, Twitter-delivered interventions offer potential for many treatment variations and titrations, thereby testing the effects of different behavior change strategies, peer-group makeups, and health behaviors of interest.ClinicalTrials.gov NCT02958189, https://clinicaltrials.gov/ct2/show/NCT02958189.DERR1-10.2196/20926.
View details for DOI 10.2196/20926
View details for PubMedID 33275104
-
Antegrade Dissection Re-Entry AfterSubintimal Wiring of an Occluded VesselFrom Spontaneous Coronary Artery Dissection.
JACC. Case reports
2020; 2 (1): 72-76
Abstract
Percutaneous management of spontaneous coronary artery dissection (SCAD) is challenging, with high procedural failurerates. We present a case of successful revascularization using antegrade dissection re-entry after failing to wirethetrue lumen in occlusive SCAD. Utilizing such alternative strategies may improve procedural success in this poorlyunderstood patient subset. (Level of Difficulty: Advanced.).
View details for DOI 10.1016/j.jaccas.2019.12.001
View details for PubMedID 34316968
-
Spontaneous Coronary Artery Dissection and ST-Segment Elevation Myocardial Infarction in an Anomalous LAD Artery
JACC: Case Reports
2020
View details for DOI 10.1016/j.jaccas.2019.11.061
-
Sex Differences in Oral Anticoagulation and Outcomes of Stroke and Intracranial Bleeding in Newly Diagnosed Atrial Fibrillation.
Journal of the American Heart Association
2020: e015689
Abstract
Background Female sex is an independent predictor of stroke in patients with atrial fibrillation (AF). Older data suggest undertreatment with anticoagulation among women compared with men. However, it is unknown if novel therapies and updated guidelines have impacted sex differences in AF treatment and outcomes. Methods and Results We performed a retrospective cohort study of 2.3 million women and men with a new diagnosis of AF and CHA2DS2-VASc ≥2 from Marketscan US commercial claims data from 2008 to 2015 to determine whether women with AF remain undertreated and whether this difference mediates observed differences in outcomes. There were 358 649 patients with newly diagnosed AF (43% women). Compared with men, women were older, with higher CHA2DS2-VASc scores, and higher comorbidity burden (P<0.0001 for all). Oral anticoagulation-eligible women with CHA2DS2-VASc scores ≥2 were more likely to not receive anticoagulation (50.0% women versus 43.9% men). Women, compared with men, had a higher risk of ischemic stroke (adjusted hazard ratio [aHR], 1.27; 95% CI, 1.21-1.32; P<0.0001) and hospitalization (aHR, 1.06; 95% CI, 1.05-1.07, P<0.0001) but had a lower risk of intracranial bleeding (aHR, 0.91; 95% CI, 0.83-0.99, P=0.03). In mediation analysis, nonreceipt of oral anticoagulation partially mediated the observed increased risk of stroke and decreased risk of intracranial bleeding in women. Conclusions In the care of newly diagnosed AF in the United States, women, compared with men, are less likely to receive oral anticoagulation. This appears to mediate the increased risk of both stroke and hospitalization but also appears to mediate lower observed intracranial bleeding risk.
View details for DOI 10.1161/JAHA.120.015689
View details for PubMedID 32394763
-
Computed Tomographic Angiography-Based Fractional Flow Reserve Compared With Catheter-Based Dobutamine-Stress Diastolic Fractional Flow Reserve in Symptomatic Patients With a Myocardial Bridge and No Obstructive Coronary Artery Disease.
Circulation. Cardiovascular imaging
2020; 13 (2): e009576
View details for DOI 10.1161/CIRCIMAGING.119.009576
View details for PubMedID 32069114
-
Off-Pump Mini Thoracotomy Versus Sternotomy for Left Anterior Descending Myocardial Bridge Unroofing.
The Annals of thoracic surgery
2020
Abstract
Myocardial bridge (MB) of the left anterior descending (LAD) coronary artery occurs in approximately 25% of the population. For patients with a symptomatic, hemodynamically significant MB who fail medical therapy, MB unroofing represents the optimal surgical management. Here, we evaluated minimally invasive MB unroofing in selected patients compared with sternotomy.MB unroofing was performed in 141 adult patients via sternotomy on-pump (ST-on, n=40), sternotomy off-pump (ST-off, n=62), or mini thoracotomy off-pump (MT, n=39). Angina symptoms were assessed preoperatively and 6-months postoperatively using the Seattle Angina Questionnaire. Matching included all MT patients and 31 ST-off patients with similar MB characteristics, no previous cardiac surgery or coronary interventions, and no concomitant procedures.MT patients tended to have a shorter MB length than ST-on and ST-off patients (2.57 vs 2.93 vs 3.09 cm, p=0.166). ST-on patients had a longer hospital stay than ST-off and MT patients (5.0 vs 4.0 vs 3.0 days, p<0.001), and more blood transfusions (15.2% vs 0.0% vs 2.6%, p=0.002). After matching, MT patients had a shorter hospital stay than ST-off patients (3.0 vs 4.0 days, p=0.005). No deaths or major complications occurred in any group. In all groups, MB unroofing yielded significant symptomatic improvement regarding physical limitation, angina stability, angina frequency, treatment satisfaction, and quality of life.We report the largest experience of off-pump minimally invasive MB unroofing, which may be safely performed in carefully selected patients, yielding dramatic improvements in angina symptomatology at 6 months after surgery.
View details for DOI 10.1016/j.athoracsur.2020.11.023
View details for PubMedID 33333083
-
A Step Back in the Diagnosis and Management of Myocardial Bridging.
The Annals of thoracic surgery
2019
View details for DOI 10.1016/j.athoracsur.2019.09.051
View details for PubMedID 31706871
-
Patient-Reported Psychological Distress After Spontaneous Coronary Artery Dissection: EVIDENCE FOR POST-TRAUMATIC STRESS.
Journal of cardiopulmonary rehabilitation and prevention
2019
Abstract
PURPOSE: High rates of depression and anxiety are reported among patients who have experienced spontaneous coronary artery dissection (SCAD) but the incidence of post-traumatic stress disorder (PTSD) is unknown. The purpose of this study was to investigate symptoms of PTSD in women who have experienced SCAD.METHODS: This cross-sectional pilot study included 14 female SCAD patients, mean age of 51 yr, who responded to standardized psychosocial questionnaires at a median of 35 mo post-SCAD. Patients were identified by cardiologists as having had a SCAD event and were concurrently invited to participate in a psychosocial group for SCAD survivors.RESULTS: Participants reported current symptoms of stress (93%), insomnia (57%), anxiety (71%), depression (36%), and PTSD (43%). Eight of the 11 women who reported having a mental health history (72.7%) indicated that their symptoms were related to having experienced SCAD. Health-related quality of life and social support were comparable with other all-female cardiac samples. Patterns of perceived control were more similar to those of patients with cancer than other cardiac patients in that SCAD patients ranked "chance" as more likely than "self-control" to impact medical outcomes.CONCLUSIONS: The prevalence of PTSD symptoms in this first-known assessment of post-traumatic stress among SCAD patients is concerning. The unexpected nature of SCAD and lack of known treatment options may play a role in patient distress. Future research is needed to accurately estimate rates of PTSD after SCAD and assess the benefits of treatment.
View details for DOI 10.1097/HCR.0000000000000460
View details for PubMedID 31343583
-
Psychological Distress Among Female Cardiac Patients Presenting to a Women's Heart Health Clinic
AMERICAN JOURNAL OF CARDIOLOGY
2019; 123 (12): 2026–30
View details for DOI 10.1016/j.amjcard.2019.03.029
View details for Web of Science ID 000472238900022
-
Psychological Distress Among Female Cardiac Patients Presenting to a Women's Heart Health Clinic.
The American journal of cardiology
2019
Abstract
Female cardiac patients are at greater risk for mental health disorders than their male counterparts, and these mental health disorders have been associated with increased cardiac morbidity and mortality. However, few studies have closely examined the mental health disorders found among the female cardiac population. The primary aim of this study was to examine the prevalence of psychological distress in a sample of female cardiac outpatients at an academic medical center. A secondary aim was to determine whether different demographic variables, cardiac risk factors, or cardiac diagnoses were associated with different levels of emotional distress. A survey, including demographic information, medical status, and standardized symptom measures was completed by 117 female patients scheduled for medical visits at an outpatient women's heart health clinic over a 4-month period. Using standardized self-report questionnaires, 38% scored in the moderate-to-severe range for at least 1 mental disorder and 50% endorsed current insomnia. Symptoms of clinical depression (20%) and anxiety (42)% were endorsed at higher rates than predominantly male or mixed comparison samples. Although there was no apparent relation between the severity of cardiac problems and the degree of psychological distress, women with diagnoses of hyperlipidemia, prediabetes, and diabetes reported greater psychological distress than those without these problems. Women with lower income also reported more psychological distress. In conclusion, our findings suggest an unmet need for integrated mental health services for female cardiac patients.
View details for PubMedID 31006484
-
EXPRESS: Myocardial Bridge - An Unrecognized Cause of Chest Pain in Pulmonary Arterial Hypertension.
Pulmonary circulation
2019: 2045894019860738
View details for DOI 10.1177/2045894019860738
View details for PubMedID 31187693
-
Asymmetric dimethylarginine predicts impaired epicardial coronary vasomotion in patients with angina in the absence of obstructive coronary artery disease.
International journal of cardiology
2019
Abstract
Impaired epicardial coronary vasomotion is a potential mechanism of angina and a predictor of adverse cardiovascular outcomes in patients without angiographic evidence of obstructive coronary artery disease (CAD). We sought to evaluate the association of asymmetric dimethylarginine (ADMA)-a marker of nitric oxide-mediated vascular dysfunction-with epicardial coronary vasomotor dysfunction in this select population.Invasive testing for epicardial vasomotor dysfunction was performed using intracoronary acetylcholine in the left anterior descending coronary artery. Impaired vasomotor response was defined as a luminal constriction of >20% on quantitative coronary angiography. Plasma ADMA levels were measured using high performance liquid chromatography. A robust multivariate linear mixed-effect model approach and Akaike information criterion were used to determine predictors of vasomotor dysfunction.In 191 patients with angina in the absence of obstructive CAD, abnormal epicardial vasomotion was observed in 137 (71.7%) patients. Median ADMA rose as the extent of impairment progressed: none (0.48 [0.44-0.59] μM), any (0.51 [0.46-0.60] μM, p = 0.12), focal (0.54 [0.49,0.61] μM, p = 0.17), and diffuse (0.55 [0.49,0.63] μM, p = 0.02). In unadjusted analysis, ADMA was highly predictive of vasomotor dysfunction (χ2=15.1, p = 0.002). Notably, ADMA remained a significant predictor even after adjusting for other factors in the best fit model (χ2=10.0, p = 0.02).ADMA is an independent predictor of epicardial coronary vasomotor dysfunction in patients with angina in the absence of obstructive CAD. These data support a very early mechanistic role of ADMA in the continuum of atherosclerotic heart disease.
View details for DOI 10.1016/j.ijcard.2019.07.062
View details for PubMedID 31416658
-
Breastfeeding Duration and the Risk of Coronary Artery Disease.
Journal of women's health (2002)
2018
Abstract
BACKGROUND: Previous studies have suggested that prolonged breastfeeding has beneficial effects on the health of the mother including the reduction of long-term risk of coronary artery disease (CAD). The mechanism of this association remains unclear.METHODS: We surveyed 643 women aged 40-65 years receiving outpatient care at Stanford University Hospital on their reproductive/lactation history, including 137 women (cases) with clinically confirmed CAD. Survey data were supplemented with traditional risk factor data for CAD obtained from the participant's medical record. We then conducted logistic regression analyses to assess the relationship between breastfeeding duration and case-control status for each of the two separate definitions of duration. The first was based on the participant's single longest duration of breastfeeding considering all live births reported and the second was based on a participant's total duration of breastfeeding summed over all live births. For each of these two definitions, we ran three sequential models each with a different reference group-(1) nulliparous women, (2) parous women that never breastfed, and (3) parous women with a short duration of breastfeeding-successively excluding women in the reference group of the previous model(s).RESULTS: Just over one-half (51.6%) of the women surveyed reported a history of breastfeeding. We found nominally significant associations (p=0.04-0.12) for our multivariate analyses that modeled maximum duration of breastfeeding. When compared with nulliparous women, parous women who either never breastfed or always breastfed for <5 months had approximately double the risk of CAD. Among parous women, women who breastfeed for ≥5 months at least once in their lifetime had a 30% decrease risk of CAD compared with those who did not initiate breastfeeding. Among parous women who breastfed ≥1 month, women who breastfed ≥5 months had 50% decreased risk of CAD. We found similar point estimates of effect for analogous analyses modeling maximum breastfeeding duration but p-values for these analyses were not significant. Unadjusted analyses demonstrated higher valued odds ratios and lower p-values suggesting the presence of some confounding by traditional risk factors.CONCLUSIONS: Parous women who breastfeed ≥5 months in at least one pregnancy seem to be at decreased risk of CAD later in their life, whereas parous women who either never breastfed or discontinued breastfeeding early seem to be at increased risk. More research is needed to more reliably quantify and determine the nature of the relationship between parity, breastfeeding duration, and risk of CAD.
View details for PubMedID 30523760
-
Breastfeeding Duration and the Risk of Coronary Artery Disease
JOURNAL OF WOMENS HEALTH
2019; 28 (1): 30–36
View details for DOI 10.1089/jwh.2018.6970
View details for Web of Science ID 000452601000001
-
The Dose-Response Relationship Between Intracoronary Acetylcholine and Minimal Lumen Diameter in Endothelial Function Testing of Women and Men With Angina in the Absence of Obstructive Coronary Artery Disease
LIPPINCOTT WILLIAMS & WILKINS. 2018
View details for Web of Science ID 000528619406032
-
Diagnostic Accuracy of a Novel Stress Echocardiography Pattern for Myocardial Bridge in Patients With Angina and No Obstructive Coronary Artery Disease - a Retrospective and Prospective Validation Cohort Study
LIPPINCOTT WILLIAMS & WILKINS. 2018
View details for Web of Science ID 000528619402033
-
Is Post-Percutaneous Coronary Intervention Fractional Flow Reserve of Value in Chronic Total Occlusions?
CIRCULATION-CARDIOVASCULAR INTERVENTIONS
2018; 11 (11)
View details for DOI 10.1161/CIRCINTERVENTIONS.118.007360
View details for Web of Science ID 000450657500012
-
Is Post-Percutaneous Coronary Intervention Fractional Flow Reserve of Value in Chronic Total Occlusions?
Circulation. Cardiovascular interventions
2018; 11 (11): e007360
View details for DOI 10.1161/CIRCINTERVENTIONS.118.007360
View details for PubMedID 30571221
-
Surgical unroofing of hemodynamically significant myocardial bridges in a pediatric population
MOSBY-ELSEVIER. 2018: 1618–26
View details for DOI 10.1016/j.jtcvs.2018.01.081
View details for Web of Science ID 000445221200079
-
Vascular Access-Related Complications in Women: Temporal Trends, Emerging Data, and the Current State of Interventional Cardiology Practice
CURRENT ATHEROSCLEROSIS REPORTS
2018; 20 (8): 41
Abstract
Women undergoing cardiac catheterization, percutaneous coronary intervention, transcatheter aortic valve replacement, and other structural heart interventions have a significantly higher risk of vascular complications and bleeding than men, leading to significant morbidity and mortality. This review highlights the importance of recognizing female sex as a specific and independent risk factor, and focuses on mechanisms of increased risk and strategies to minimize that risk. Smaller caliber peripheral vessels, low body weight, variations in platelet reactivity, and inappropriate dosing of anticoagulant and antiplatelet agents are the currently identified mechanisms for elevated bleeding and vascular complication risk in women. Radial-preferred access, smaller caliber sheaths, imaging-guided arterial puncture, and more judicious anticoagulant dosing have led to reduced bleeding and vascular complication rates in both sexes, especially women. Obtaining proficiency in these strategies should be a priority for operators in order to improve safety and procedural outcomes in women.
View details for PubMedID 29884916
-
Surgical unroofing of hemodynamically significant myocardial bridges in a pediatric population.
The Journal of thoracic and cardiovascular surgery
2018
Abstract
BACKGROUND: Although myocardial bridges (MBs) are traditionally regarded as incidental findings, it has been reported that adult patients with symptomatic MBs refractory to medical therapy benefit from unroofing. However, there is limited literature in the pediatric population. The aim of our study was to evaluate the indications and outcomes for unroofing in pediatric patients.METHODS: We retrospectively reviewed all pediatric patients with MB in our institution who underwent surgical relief. Clinical characteristics, relevant diagnostic data, intraoperative findings, and postoperative outcomes were evaluated.RESULTS: Between 2012 and 2016, 14 pediatric patients underwent surgical unroofing of left anterior descending artery MBs. Thirteen patients had anginal symptoms refractory to medical therapy, and 1 patient was asymptomatic until experiencing aborted sudden cardiac arrest during exercise. Thirteen patients underwent exercise stress echocardiography, all of which showed mid-septal dys-synergy. Coronary computed tomography imaging confirmed the presence of MBs in all patients. Intravascular ultrasound imaging confirmed the length of MBs: 28.2±16.3mm, halo thickness: 0.59±0.24mm, and compression of left anterior descending artery at resting heart rate: 33.0±11.6%. Invasive hemodynamic assessment with dobutamine confirmed the physiologic significance of the MBs with diastolic fractional flow reserve: 0.59±0.13. Unroofing was performed with the patient under cardiopulmonary bypass (CPB) in the initial 9 cases and without CPB in the subsequent 5 cases. All patients were discharged without complications. The 13 symptomatic patients reported resolution of symptoms on follow-up, and improvement in symptoms and quality of life was documented using the Seattle Angina Questionnaire version 7.CONCLUSIONS: Unroofing of MBs can be safely performed in pediatric patients, with or without use of CPB. In symptomatic patients, unroofing can provide relief of symptoms refractory to medical therapy.
View details for PubMedID 30005887
-
EFFECT OF RANOLAZINE ON SYMPTOMS AND QUALITY OF LIFE IN PATIENTS WITH ANGINA IN THE ABSENCE OF OBSTRUCTIVE CORONARY ARTERY DISEASE: A RETROSPECTIVE COHORT STUDY
ELSEVIER SCIENCE INC. 2018: 161
View details for DOI 10.1016/S0735-1097(18)30702-2
View details for Web of Science ID 000429659701011
-
SUBCLINICAL LEFT VENTRICULAR DYSFUNCTION IN WOMEN WITH ANGINA IN THE ABSENCE OF OBSTRUCTIVE CORONARY ARTERY DISEASE: A COMPREHENSIVE INVASIVE AND ECHOCARDIOGRAPHIC STUDY
ELSEVIER SCIENCE INC. 2018: 132
View details for DOI 10.1016/S0735-1097(18)30673-9
View details for Web of Science ID 000429659700133
-
MYOCARDIAL BRIDGE MUSCLE INDEX (MMI): A MARKER OF DISEASE SEVERITY AND ITS RELATIONSHIP WITH ENDOTHELIAL DYSFUNCTION AND SYMPTOMATIC OUTCOME IN PATIENTS WITH ANGINA AND A HEMODYNAMICALLY SIGNIFICANT MYOCARDIAL BRIDGE
ELSEVIER SCIENCE INC. 2018: 160
View details for DOI 10.1016/S0735-1097(18)30701-0
View details for Web of Science ID 000429659701010
-
Accuracy of non-invasive stress testing in women and men with angina in the absence of obstructive coronary artery disease.
International journal of cardiology
2018
Abstract
While >20% of patients presenting to the cardiac catheterization laboratory with angina have no obstructive coronary artery disease (CAD), a majority (77%) have an occult coronary abnormality (endothelial dysfunction, microvascular dysfunction (MVD), and/or a myocardial bridge (MB)). There are little data regarding the ability of noninvasive stress testing to identify these occult abnormalities in patients with angina in the absence of obstructive CAD.We retrospectively evaluated 155 patients (76.7% women) with angina and no obstructive CAD who underwent stress echocardiography and/or electrocardiography before angiography. We evaluated Duke treadmill score, heart rate recovery (HRR), metabolic equivalents, and blood pressure response. During angiography, patients underwent invasive testing for endothelial dysfunction (decrease in epicardial coronary artery diameter >20% after intracoronary acetylcholine), MVD (index of microcirculatory resistance ≥25), and intravascular ultrasound for the presence of an MB.Stress echocardiography and electrocardiography were positive in 58 (43.6%) and 57 (36.7%) patients, respectively. Endothelial dysfunction was present in 96 (64%), MVD in 32 (20.6%), and an MB in 83 (53.9%). On multivariable logistic regression, stress echo was not associated with any abnormality, while stress ECG was associated with endothelial dysfunction. An abnormal HRR was associated with endothelial dysfunction and MVD, but not an MB.Conventional stress testing is insufficient for identifying occult coronary abnormalities that are frequently present in patients with angina in the absence of obstructive CAD. A normal stress test does not rule out a non-obstructive coronary etiology of angina, nor does it negate the need for comprehensive invasive testing.
View details for DOI 10.1016/j.ijcard.2018.10.073
View details for PubMedID 30527992
-
Late breaking trials of 2016 in coronary artery disease: Commentary covering SCAI, ACC, TCT, EuroPCR, ESC, and AHA.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
2017; 89 (6): 1028-1034
Abstract
The SCAI Publications Committee and Emerging Leadership Mentorship (ELM) Fellows concisely summarize and provide context on the most important coronary trials presented at large international meetings in 2016, including SCAI, ACC, TCT, EuroPCR, ESC, and AHA. The intent is to allow quick assimilation of trial results into interventional practice, and enable busy interventional cardiologists to stay up to date. © 2017 Wiley Periodicals, Inc.
View details for DOI 10.1002/ccd.26940
View details for PubMedID 28276150
-
SEX DIFFERENCES IN THE RISK FACTORS FOR ENDOTHELIAL AND MICROVASCULAR DYSFUNCTION IN PATIENTS WITH ANGINA IN THE ABSENCE OF OBSTRUCTIVE CORONARY ARTERY DISEASE
ELSEVIER SCIENCE INC. 2017: 1749
View details for Web of Science ID 000397342302471
-
PSYCHOLOGICAL DISTRESS IN FEMALE PATIENTS WITH SPONTANEOUS CORONARY ARTERY DISSECTION
OXFORD UNIV PRESS INC. 2017: S2483
View details for Web of Science ID 000398947203254
-
Myocardial Bridges on Coronary Computed Tomography Angiography - Correlation With Intravascular Ultrasound and Fractional Flow Reserve.
Circulation journal : official journal of the Japanese Circulation Society
2017
Abstract
Myocardial bridges (MB) are commonly seen on coronary CT angiography (CCTA) in asymptomatic individuals, but in patients with recurrent typical angina symptoms, yet no obstructive coronary artery disease (CAD), evaluation of their potential hemodynamic significance is clinically relevant. The aim of this study was to compare CCTA to invasive coronary angiography (ICA), including intravascular ultrasound (IVUS), to confirm MB morphology and estimate their functional significance in symptomatic patients.Methods and Results:We retrospectively identified 59 patients from our clinical databases between 2009 and 2014 in whom the suspicion for MB was raised by symptoms of recurrent typical angina in the absence of significant obstructive CAD on ICA. All patients underwent CCTA, ICA and IVUS. MB length and depth by CCTA agreed well with length (0.6±23.7 mm) and depth (CT coverage) as seen on IVUS. The product of CT length and depth (CT coverage), (MB muscle index (MMI)), ≥31 predicted an abnormal diastolic fractional flow reserve (dFFR) ≤0.76 with a sensitivity and specificity of 74% and 62% respectively (area under the curve=0.722).In patients with recurrent symptoms of typical angina yet no obstructive CAD, clinicians should consider dynamic ischemia from an MB in the differential diagnosis. The product of length and depth (i.e., MMI) by CCTA may provide some non-invasive insight into the hemodynamic significance of a myocardial bridge, as compared with invasive assessment with dFFR.
View details for PubMedID 28690285
-
Myocardial Bridges on Coronary Computed Tomography Angiography - Correlation With Intravascular Ultrasound and Fractional Flow Reserve.
Circulation Journal
2017
View details for DOI 10.1253/circj.CJ-17-0284
-
Pyruvate controls the checkpoint inhibitor PD-L1 and suppresses T cell immunity.
The Journal of clinical investigation
2017; 127 (7): 2725–38
Abstract
Patients with coronary artery disease (CAD) are at high risk for reactivation of the varicella zoster virus (VZV) and development of herpes zoster (HZ). Here, we found that macrophages from patients with CAD actively suppress T cell activation and expansion, leading to defective VZV-specific T cell immunity. Monocyte-derived and plaque-infiltrating macrophages from patients with CAD spontaneously expressed high surface density of the immunoinhibitory ligand programmed death ligand-1 (PD-L1), thereby providing negative signals to programmed death-1+ (PD-1+) T cells. We determined that aberrant PD-L1 expression in patient-derived macrophages was metabolically controlled. Oversupply of the glycolytic intermediate pyruvate in mitochondria from CAD macrophages promoted expression of PD-L1 via induction of the bone morphogenetic protein 4/phosphorylated SMAD1/5/IFN regulatory factor 1 (BMP4/p-SMAD1/5/IRF1) signaling pathway. Thus, CAD macrophages respond to nutrient excess by activating the immunoinhibitory PD-1/PD-L1 checkpoint, leading to impaired T cell immunity. This finding indicates that metabolite-based immunotherapy may be a potential strategy for restoring adaptive immunity in CAD.
View details for PubMedID 28604383
-
Myocardial bridges: Overview of diagnosis and management.
Congenital heart disease
2017
Abstract
A myocardial bridge is a segment of a coronary artery that travels into the myocardium instead of the normal epicardial course. Although it is general perception that myocardial bridges are normal variants, patients with myocardial bridges can present with symptoms, such as exertional chest pain, that cannot be explained by a secondary etiology. Such patients may benefit from individualized medical/surgical therapy. This article describes the prevalence, clinical presentation, classification, evaluation, and management of children and adults with symptomatic myocardial bridges.
View details for PubMedID 28675696
-
Myocardial bridging is associated with exercise-induced ventricular arrhythmia and increases in QT dispersion.
Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc
2017
Abstract
A myocardial bridge (MB) has been associated with ventricular arrhythmia and sudden death during exercise. QT dispersion (QTd) is a measure of abnormal repolarization and may predict ventricular arrhythmia. We investigated the frequency of ventricular arrhythmias during exercise and the QTd at rest and after exercise, in patients with an MB compared to a normal cohort.We studied the rest and stress ECG tracings of patients with an MB suspected by focal septal buckling on exercise echocardiography (EE) (Echo-MB group, N = 510), those with an MB confirmed by another examination (MB group, N = 110), and healthy controls (Control group, N = 198).The frequency of exercise-induced premature ventricular contractions (PVCs) was significantly higher in the Echo-MB and MB groups compared with the Control group (both p < .001). In all, 25 patients (4.9%) in the Echo-MB group, seven patients (6.4%) in the MB group and no patients in the Control group had exercise-induced non-sustained ventricular tachycardia (NSVT). There was no difference in the baseline QTd between the groups. In the Echo-MB and MB groups, QTd postexercise increased significantly when compared with baseline (both p < .001). Patients with NSVT had a higher frequency of male gender and an even greater increase in QTd with exercise compared with the non-NSVT group.There is an increased frequency of exercise-induced PVCs and NSVT in patients with MBs. Exercise significantly increases QTd in MB patients, with an even greater increase in QTd in MB patients with NSVT. Exercise in MB patients results in ventricular arrhythmias and abnormalities in repolarization.
View details for PubMedID 28921787
-
Myocardial Bridge and Acute Plaque Rupture.
Journal of investigative medicine high impact case reports
2016; 4 (4): 2324709616680227-?
Abstract
A myocardial bridge (MB) is a common anatomic variant, most frequently located in the left anterior descending coronary artery, where a portion of the coronary artery is covered by myocardium. Importantly, MBs are known to result in a proximal atherosclerotic lesion. It has recently been postulated that these lesions predispose patients to acute coronary events, even in cases of otherwise low-risk patients. One such mechanism may involve acute plaque rupture. In this article, we report 2 cases of patients with MBs who presented with acute coronary syndromes despite having low cardiovascular risk. Their presentation was life-risking and both were treated urgently and studied with coronary angiographies and intravascular ultrasound. This latter modality confirmed a rupture of an atherosclerotic plaque proximal to the MB as a likely cause of the acute events. These cases, of unexplained acute coronary syndrome in low-risk patients, raise the question of alternative processes leading to the event and the role MB play as an underlying cause of ruptured plaques. In some cases, an active investigation for this entity may be warranted, due to the prognostic implications of the different therapeutic modalities, should an MB be discovered.
View details for DOI 10.1177/2324709616680227
View details for PubMedID 28251167
-
Surgical Unroofing of Hemodynamically Significant Left Anterior Descending Myocardial Bridges.
Annals of thoracic surgery
2016
Abstract
Left anterior descending artery myocardial bridges (MBs) range from clinically insignificant incidental angiographic findings to a potential cause of sudden cardiac death. Within this spectrum, a group of patients with isolated, symptomatic, and hemodynamically significant MBs despite maximally tolerated medical therapy exist for whom the optimal treatment is controversial. We evaluated supraarterial myotomy, or surgical unroofing, of the left anterior descending MBs as an isolated procedure in these patients.In 50 adult patients, we prospectively evaluated baseline clinical characteristics, risk factors, and medications for coronary artery disease, relevant diagnostic data (stress echocardiography, computed tomography angiography, stress coronary angiogram with dobutamine challenge for measurement of diastolic fractional flow reserve, and intravascular ultrasonography), and anginal symptoms using the Seattle Angina Questionnaire. These patients then underwent surgical unroofing of their left anterior descending artery MBs followed by readministration of the Seattle Angina Questionnaire at 6.6-month (range, 2 to 13) follow-up after surgery.Dramatic improvements were noted in physical limitation due to angina (52.0 versus 87.1, p < 0.001), anginal stability (29.6 versus 66.4, p < 0.001), anginal frequency (52.1 versus 84.7, p < 0.001), treatment satisfaction (76.1 versus 93.9, p < 0.001), and quality of life (25.0 versus 78.9, p < 0.001), all five dimensions of the Seattle Angina Questionnaire. There were no major complications or deaths.Surgical unroofing of carefully selected patients with MBs can be performed safely as an independent procedure with significant improvement in symptoms postoperatively. It is the optimal treatment for isolated, symptomatic, and hemodynamically significant MBs resistant to maximally tolerated medical therapy.
View details for DOI 10.1016/j.athoracsur.2016.08.035
View details for PubMedID 27745841
-
Late Breaking Trials of 2015 in Coronary Artery Disease: Commentary Covering ACC, EuroPCR, SCAI, TCT, ESC, and AHA
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
2016; 87 (7): 1224-1230
Abstract
The SCAI Publications Committee and Emerging Leadership Mentorship (ELM) Fellows concisely summarize and provide context on the most important coronary trials presented at large international meetings in 2015, including the MATRIX, ABSORB, and TOTAL trials. The intent is to allow quick assimilation of trial results into interventional practice, and enable busy interventional cardiologists to stay up to date. © 2016 Wiley Periodicals, Inc.
View details for DOI 10.1002/ccd.26474
View details for Web of Science ID 000379985100013
View details for PubMedID 26946364
-
EFFECT OF SURGICAL UNROOFING OF A MYOCARDIAL BRIDGE ON EXERCISE INDUCED QT INTERVAL DISPERSION AND ANGINAL SYMPTOMS IN PATIENTS WITH ANGINA IN THE ABSENCE OF OBSTRUCTIVE CORONARY ARTERY DISEASE
ELSEVIER SCIENCE INC. 2016: 2150
View details for DOI 10.1016/S0735-1097(16)32151-9
View details for Web of Science ID 000375188702996
-
LACTATION AND FUTURE CARDIOVASCULAR DISEASE IN WOMEN: AN UNDER APPRECIATED TARGET FOR PREVENTION
ELSEVIER SCIENCE INC. 2016: 1859
View details for DOI 10.1016/S0735-1097(16)31860-5
View details for Web of Science ID 000375188702705
-
FRACTIONAL FLOW RESERVE IN PATIENTS WITH ANGINA IN THE ABSENCE OF OBSTRUCTIVE CORONARY ARTERY DISEASE: IS THERE SUCH A THING AS NORMAL CORONARY ARTERIES?
ELSEVIER SCIENCE INC. 2016: 375
View details for DOI 10.1016/S0735-1097(16)30376-X
View details for Web of Science ID 000375188701219
-
EARLY ASSOCIATION OF ASYMMETRIC DIMETHYLARGININE WITH ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH ANGINA AND NONOBSTRUCTIVE CORONARY ARTERY DISEASE
ELSEVIER SCIENCE INC. 2016: 2137
View details for DOI 10.1016/S0735-1097(16)32138-6
View details for Web of Science ID 000375188702983
-
CLINICAL PRESENTATION, MANAGEMENT AND PROGNOSIS OF PATIENTS WITH SPONTANEOUS CORONARY ARTERY DISSECTION
ELSEVIER SCIENCE INC. 2016: 53
View details for DOI 10.1016/S0735-1097(16)30054-7
View details for Web of Science ID 000375188700054
-
Bilateral Giant Coronary Artery Aneurysms Complicated by Acute Coronary Syndrome and Cardiogenic Shock.
Annals of thoracic surgery
2016; 101 (4): e95-7
Abstract
Giant coronary aneurysms are rare. We present a 25-year-old woman with a known history of non-Kawasaki/nonatherosclerotic bilateral coronary aneurysms. She was transferred to our facility with acute coronary syndrome complicated by cardiogenic shock. Angiography demonstrated giant bilateral coronary aneurysms and complete occlusion of the left anterior descending (LAD) artery. Emergent coronary artery bypass grafting was performed. Coronary artery bypass grafting is the preferred approach for addressing giant coronary aneurysms. Intervention on the aneurysm varies in the literature. Aggressive revascularization is recommended in the non-Kawasaki/nonatherosclerotic aneurysm patient, and ligation should be performed in patients with thromboembolic phenomena.
View details for DOI 10.1016/j.athoracsur.2015.06.104
View details for PubMedID 27000621
-
Functional Versus Anatomic Assessment of Myocardial Bridging by Intravascular Ultrasound: Impact of Arterial Compression on Proximal Atherosclerotic Plaque.
Journal of the American Heart Association
2016; 5 (4)
Abstract
The presence of a myocardial bridge (MB) has been shown to promote atherosclerotic plaque formation proximal to the MB, presumably because of hemodynamic disturbances provoked by retrograde blood flow toward this segment in cardiac systole. We aimed to determine the anatomic and functional properties of an MB related to the extent of atherosclerosis assessed by intravascular ultrasound.We enrolled 100 patients with angina but no significant obstructive coronary artery disease who had an intravascular ultrasound-detected MB in the left anterior descending artery (median age 54 years, 36% male). The MB was identified with intravascular ultrasound by the presence of an echolucent band (halo). Anatomically, the MB length was 22±13 mm, and halo thickness was 0.7±0.6 mm. Functionally, systolic arterial compression was 23±12%. The maximum plaque burden up to 20 mm proximal to the MB entrance was significantly greater than the maximum plaque burden within the MB segment. Among the intravascular ultrasound-defined MB properties, arterial compression was the sole MB parameter that demonstrated a significant positive correlation with maximum plaque burden up to 20 mm proximal to the MB entrance (r=0.254, P=0.011 overall; r=0.545, P<0.001 low coronary risk). In multivariate analysis, adjusting for clinical characteristics and coronary risk factors, arterial compression was independently associated with maximum plaque burden up to 20 mm proximal to the MB entrance.In patients with an MB in the left anterior descending artery, the percentage of arterial compression is related directly to the burden of atherosclerotic plaque located proximally to the MB, particularly in patients who otherwise have low coronary risk. This may prove helpful in identifying high-risk MB patients.
View details for DOI 10.1161/JAHA.114.001735
View details for PubMedID 27098967
-
To Define Is to Limit: Is That Good or Bad When it Comes to Chest Pain?
JACC. Cardiovascular interventions
2016; 9 (6): 562–64
View details for PubMedID 26947385
-
Investing in our future: Update on the SCAI Emerging Leader Mentorship (ELM) Program.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
2016; 88 (5): 674–77
View details for PubMedID 27865069
-
Response to Letters Regarding Article, "Invasive Evaluation of Patients With Angina in the Absence of Obstructive Coronary Artery Disease"
CIRCULATION
2015; 132 (20): E244
View details for PubMedID 26572677
-
Exercise Strain Echocardiography in Patients With a Hemodynamically Significant Myocardial Bridge Assessed by Physiological Study.
Journal of the American Heart Association
2015; 4 (11)
Abstract
Although a myocardial bridge (MB) is often regarded as a benign coronary variant, recent studies have associated MB with focal myocardial ischemia. The physiological consequences of MB on ventricular function during stress have not been well established.We enrolled 58 patients with MB of the left anterior descending artery, diagnosed by intravascular ultrasound. Patients underwent invasive physiological evaluation of the MB by diastolic fractional flow reserve during dobutamine challenge and exercise echocardiography. Septal and lateral longitudinal strain (LS) were assessed at rest and immediately after exercise and compared with strain of matched controls. Absolute and relative changes in strain were also calculated. The mean age was 42.5±16.0 years. Fifty-five patients had a diastolic fractional flow reserve ≤0.76. At rest, there was no significant difference between the 2 groups in septal LS (19.0±1.8% for patients with MB versus 19.2±1.5% for control, P=0.53) and lateral LS (20.1±2.0% versus 20.0±1.6%, P=0.83). With stress, compared with controls, patients with MB had a lower peak septal LS (18.9±2.6% versus 21.7±1.6%, P<0.001) and lower absolute (-0.1±2.1% versus 2.5±1.3%, P<0.001) and relative change (-0.6±11.2% versus 13.1±7.8%, P<0.001) in septal LS, whereas there was no significant difference in lateral LS. In multivariate analysis, diastolic fractional flow reserve and length were independent determinants of lower changes in septal LS.Patients with a hemodynamically significant MB, determined by invasive diastolic fractional flow reserve, have significantly lower change in septal LS on exercise echocardiography, suggesting that septal LS may be useful for noninvasively assessing the hemodynamic significance of an MB.
View details for DOI 10.1161/JAHA.115.002496
View details for PubMedID 26581225
-
How Can We Further Optimize the Invasive Evaluation of Coronary Physiology?
JACC-CARDIOVASCULAR INTERVENTIONS
2015; 8 (13): 1692–94
View details for PubMedID 26585619
-
Exercise Strain Echocardiography in Patients With a Hemodynamically Significant Myocardial Bridge Assessed by Physiological Study
JOURNAL OF THE AMERICAN HEART ASSOCIATION
2015; 4 (11)
Abstract
Although a myocardial bridge (MB) is often regarded as a benign coronary variant, recent studies have associated MB with focal myocardial ischemia. The physiological consequences of MB on ventricular function during stress have not been well established.We enrolled 58 patients with MB of the left anterior descending artery, diagnosed by intravascular ultrasound. Patients underwent invasive physiological evaluation of the MB by diastolic fractional flow reserve during dobutamine challenge and exercise echocardiography. Septal and lateral longitudinal strain (LS) were assessed at rest and immediately after exercise and compared with strain of matched controls. Absolute and relative changes in strain were also calculated. The mean age was 42.5±16.0 years. Fifty-five patients had a diastolic fractional flow reserve ≤0.76. At rest, there was no significant difference between the 2 groups in septal LS (19.0±1.8% for patients with MB versus 19.2±1.5% for control, P=0.53) and lateral LS (20.1±2.0% versus 20.0±1.6%, P=0.83). With stress, compared with controls, patients with MB had a lower peak septal LS (18.9±2.6% versus 21.7±1.6%, P<0.001) and lower absolute (-0.1±2.1% versus 2.5±1.3%, P<0.001) and relative change (-0.6±11.2% versus 13.1±7.8%, P<0.001) in septal LS, whereas there was no significant difference in lateral LS. In multivariate analysis, diastolic fractional flow reserve and length were independent determinants of lower changes in septal LS.Patients with a hemodynamically significant MB, determined by invasive diastolic fractional flow reserve, have significantly lower change in septal LS on exercise echocardiography, suggesting that septal LS may be useful for noninvasively assessing the hemodynamic significance of an MB.
View details for DOI 10.1161/JAHA.115.002496
View details for Web of Science ID 000366615600020
View details for PubMedID 26581225
-
Association between Increased Number of Septal Branches within the Myocardial Bridge and Abnormal Diastolic-Fractional Flow Reserve
ELSEVIER SCIENCE INC. 2015: B139–B140
View details for DOI 10.1016/j.jacc.2015.08.964
View details for Web of Science ID 000363329000305
-
Effect of Sex Differences on Invasive Measures of Coronary Microvascular Dysfunction in Patients With Angina in the Absence of Obstructive Coronary Artery Disease
JACC-CARDIOVASCULAR INTERVENTIONS
2015; 8 (11): 1433-1441
Abstract
This study investigated sex differences in coronary flow reserve (CFR) and the index of microcirculatory resistance (IMR) in patients with angina in the absence of obstructive coronary artery disease.Coronary microvascular dysfunction is associated with worse long-term outcomes, especially in women. Coronary flow reserve (CFR) and the index of microcirculatory resistance (IMR) are 2 methods of assessing the coronary microcirculation.We prospectively enrolled 117 women and 40 men with angina in the absence of obstructive coronary artery disease. We performed CFR, IMR, fractional flow reserve, and quantitative coronary angiography in the left anterior descending artery. Coronary flow was assessed with a thermodilution method by obtaining mean transit time (Tmn) (an inverse correlate to absolute flow) at rest and hyperemia.All patients had minimal atherosclerosis by quantitative coronary angiography (% diameter stenosis: 23.2 ± 12.3%), and epicardial disease was milder in women (fractional flow reserve: 0.88 ± 0.04 vs. 0.87 ± 0.04; p = 0.04). IMR was similar between the sexes (20.7 ± 9.8 vs. 19.1 ± 8.0; p = 0.45), but CFR was lower in women (3.8 ± 1.6 vs. 4.8 ± 1.9; p = 0.004). This was primarily due to a shorter resting Tmn in women (p = 0.005), suggesting increased resting coronary flow, whereas hyperemic Tmn was identical (p = 0.79). In multivariable analysis, female sex was an independent predictor of lower CFR and shorter resting Tmn.Despite similar microvascular function in women and men by IMR, CFR is lower in women. This discrepancy appears to be due to differences in resting coronary flow between the sexes. The effect of sex differences should be considered in interpretation of physiological indexes using resting coronary flow.
View details for DOI 10.1016/j.jcin.2015.03.045
View details for Web of Science ID 000361757600013
-
Effect of Sex Differences on Invasive Measures of Coronary Microvascular Dysfunction in Patients With Angina in the Absence of Obstructive Coronary Artery Disease.
JACC. Cardiovascular interventions
2015; 8 (11): 1433-41
Abstract
This study investigated sex differences in coronary flow reserve (CFR) and the index of microcirculatory resistance (IMR) in patients with angina in the absence of obstructive coronary artery disease.Coronary microvascular dysfunction is associated with worse long-term outcomes, especially in women. Coronary flow reserve (CFR) and the index of microcirculatory resistance (IMR) are 2 methods of assessing the coronary microcirculation.We prospectively enrolled 117 women and 40 men with angina in the absence of obstructive coronary artery disease. We performed CFR, IMR, fractional flow reserve, and quantitative coronary angiography in the left anterior descending artery. Coronary flow was assessed with a thermodilution method by obtaining mean transit time (Tmn) (an inverse correlate to absolute flow) at rest and hyperemia.All patients had minimal atherosclerosis by quantitative coronary angiography (% diameter stenosis: 23.2 ± 12.3%), and epicardial disease was milder in women (fractional flow reserve: 0.88 ± 0.04 vs. 0.87 ± 0.04; p = 0.04). IMR was similar between the sexes (20.7 ± 9.8 vs. 19.1 ± 8.0; p = 0.45), but CFR was lower in women (3.8 ± 1.6 vs. 4.8 ± 1.9; p = 0.004). This was primarily due to a shorter resting Tmn in women (p = 0.005), suggesting increased resting coronary flow, whereas hyperemic Tmn was identical (p = 0.79). In multivariable analysis, female sex was an independent predictor of lower CFR and shorter resting Tmn.Despite similar microvascular function in women and men by IMR, CFR is lower in women. This discrepancy appears to be due to differences in resting coronary flow between the sexes. The effect of sex differences should be considered in interpretation of physiological indexes using resting coronary flow.
View details for DOI 10.1016/j.jcin.2015.03.045
View details for PubMedID 26404195
-
Invasive physiologic and anatomic multimodality assessment of myocardial bridging.
Coronary artery disease
2015; 26: e38-40
View details for DOI 10.1097/MCA.0000000000000206
View details for PubMedID 26247269
-
Preventing Radial Artery Occlusion by Using Reverse Barbeau Assessment: Bringing Evidence-Based Practice to the Bedside.
Critical care nurse
2015; 35 (4): 77-82
View details for DOI 10.4037/ccn2015428
View details for PubMedID 26232806
-
Late breaking trials of 2014 in coronary artery disease: Commentary covering ACC, EuroPCR, SCAI, TCT, ESC, and AHA.
Catheterization and cardiovascular interventions
2015; 86 (1): 73-79
Abstract
With the plethora of clinical trials, it is difficult for busy interventional cardiologists to stay up to date. Therefore, the SCAI Publications Committee concisely summarizes and provides editorial commentary on the most important coronary trials from the large international meetings of 2014. The intent is to allow quick assimilation of trial results into interventional practice. © 2015 Wiley Periodicals, Inc.
View details for DOI 10.1002/ccd.25942
View details for PubMedID 25854985
-
Prevalence and Prognostic Role of Right Ventricular Involvement in Stress-Induced Cardiomyopathy
JOURNAL OF CARDIAC FAILURE
2015; 21 (5): 419-425
Abstract
Stress-induced cardiomyopathy (SCM) is a reversible cardiomyopathy observed in patients without significant coronary disease. The aim of this study was to assess the incidence and clinical significance of right ventricular (RV) involvement in SCM.We retrospectively analyzed echocardiograms from 40 consecutive patients who presented with SCM at Stanford University Medical Center from September 2000 to November 2010. The primary end point was overall mortality. RV involvement was observed in 20 patients (50%; global RV hypokinesia in 15 patients and focal RV apical akinesia in 5 patients). The independent correlates of RV involvement were older age (odds ratio [OR] 1.09, 95% confidence interval [CI] 1.02-1.7two, P = .01) and LVEF (per 10% decrease: OR 3.60, CI 1.77-7.32; P = .02). At a mean follow-up of 44 ± 32 months, 12 patients (30%) died (in-hospital death in 3 patients). At multivariate analysis, the presence of an RV fractional area change <35% emerged as an independent predictor of death (OR 3.6, CI 1.06-12.41; P = .04).RV involvement is a common finding in SCM, and may present as either global or focal RV apical involvement. Both older age and lower LVEF are associated with a higher risk of RV involvement, which appears to be a major predictor of death.
View details for DOI 10.1016/j.cardfail.2015.02.001
View details for PubMedID 25704104
-
Invasive Evaluation of Patients With Angina in the Absence of Obstructive Coronary Artery Disease
CIRCULATION
2015; 131 (12): 1054-1060
Abstract
More than 20% of patients presenting to the cardiac catheterization laboratory with angina have no angiographic evidence of coronary artery disease. Despite a "normal" angiogram, these patients often have persistent symptoms, recurrent hospitalizations, a poor functional status, and adverse cardiovascular outcomes, without a clear diagnosis.In 139 patients with angina in the absence of obstructive coronary artery disease (no diameter stenosis >50%), endothelial function was assessed; the index of microcirculatory resistance, coronary flow reserve, and fractional flow reserve were measured; and intravascular ultrasound was performed. There were no complications. The average age was 54.0±11.4 years, and 107 (77%) were women. All patients had at least some evidence of atherosclerosis based on an intravascular ultrasound examination of the left anterior descending artery. Endothelial dysfunction (a decrease in luminal diameter of >20% after intracoronary acetylcholine) was present in 61 patients (44%). Microvascular impairment (an index of microcirculatory resistance ≥25) was present in 29 patients (21%). Seven patients (5%) had a fractional flow reserve ≤0.80. A myocardial bridge was present in 70 patients (58%). Overall, only 32 patients (23%) had no coronary explanation for their angina, with normal endothelial function, normal coronary physiological assessment, and no myocardial bridging.The majority of patients with angina in the absence of obstructive coronary artery disease have occult coronary abnormalities. A comprehensive invasive assessment of these patients at the time of coronary angiography can be performed safely and provides important diagnostic information that may affect treatment and outcomes.
View details for DOI 10.1161/CIRCULATIONAHA.114.012636
View details for PubMedID 25712205
-
SEX DIFFERENCES IN CORONARY PATHOPHYSIOLOGY IN PATIENTS WITH ANGINA IN THE ABSENCE OF OBSTRUCTIVE CORONARY ARTERY DISEASE
ELSEVIER SCIENCE INC. 2015: A1859
View details for DOI 10.1016/S0735-1097(15)61859-9
View details for Web of Science ID 000375328802181
-
IMPACT OF MYOCARDIAL DEFORMATION IMAGING ON THE DIAGNOSIS OF MYOCARDIAL BRIDGE: PHYSIOLOGIC AND STRAIN ECHOCARDIOGRAPHIC STUDY
ELSEVIER SCIENCE INC. 2015: A1208
View details for DOI 10.1016/S0735-1097(15)61208-6
View details for Web of Science ID 000375328801528
-
THE DIAGNOSTIC VALUE OF STRESS ECHOCARDIOGRAPHY AND ELECTROCARDIOGRAPHY IN IDENTIFYING OCCULT CORONARY ABNORMALITIES IN PATIENTS WITH ANGINA AND NO OBSTRUCTIVE CORONARY ARTERY DISEASE
ELSEVIER SCIENCE INC. 2015: A1623
View details for DOI 10.1016/S0735-1097(15)61623-0
View details for Web of Science ID 000375328801943
-
THE EFFECT OF MINDFULNESS-BASED STRESS REDUCTION ON ANGINA AND VASCULAR FUNCTION IN WOMEN WITH NON-OBSTRUCTIVE CORONARY ARTERY DISEASE
ELSEVIER SCIENCE INC. 2015: A1658
View details for DOI 10.1016/S0735-1097(15)61658-8
View details for Web of Science ID 000375328801978
-
The relationship between fractional flow reserve and index of microcirculatory resistance: be careful with whom you associate.
Catheterization and cardiovascular interventions
2015; 85 (4): 593-594
View details for DOI 10.1002/ccd.25850
View details for PubMedID 25702909
-
Commentary on Highlighted Late Breaking Trials in Interventional Cardiology at ESC, VIVA, TCT, and AHA 2013
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
2015; 85 (1): 95-103
Abstract
With the plethora of clinical trials, it is difficult for busy interventional cardiologists to stay up to date. Therefore, the SCAI publications committee concisely summarizes and provides editorial commentary on the most important trials from recent, large international meetings. The intent is to provide this summary every six months to allow quick assimilation of trial results into interventional practice. © 2014 Wiley Periodicals, Inc.
View details for DOI 10.1002/ccd.25635
View details for Web of Science ID 000346479900025
View details for PubMedID 25115350
-
Invasive physiologic and anatomic multimodality assessment of myocardial bridging
Coronary Artery Disease
2015: 38-40
View details for DOI 10.1097/MCA.0000000000000206
-
Rebuttal: Response to Letter by Chugh S. Regarding "Best Practices for Transradial Angiography and Intervention: A Consensus Statement from the Society for Cardiovascular Angiography and Intervention's Transradial Working Group"
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
2015; 85 (1): 177
View details for DOI 10.1002/ccd.25506
View details for Web of Science ID 000346479900038
View details for PubMedID 24740579
-
Myocardial bridging.
Journal of the American College of Cardiology
2014; 64 (20): 2178-2179
View details for DOI 10.1016/j.jacc.2014.07.993
View details for PubMedID 25457408
-
Continuous flow left ventricular assist device placement complicated by aortic valve thrombus and myocardial infarction
INTERNATIONAL JOURNAL OF CARDIOLOGY
2014; 176 (3): E102-E103
View details for DOI 10.1016/j.ijcard.2014.07.248
View details for Web of Science ID 000343893300011
-
Continuous flow left ventricular assist device placement complicated by aortic valve thrombus and myocardial infarction.
International journal of cardiology
2014; 176 (3): e102-3
View details for DOI 10.1016/j.ijcard.2014.07.248
View details for PubMedID 25183539
-
Impact of Coronary Artery Size on Physiologic Microcirculatory Indices: A Volumetric Intravascular Ultrasound Study with Coronary Flow Assessment
ELSEVIER SCIENCE INC. 2014: B91
View details for DOI 10.1016/j.jacc.2014.07.362
View details for Web of Science ID 000359649700312
-
Atherosclerotic Plaque Formation Relates to Myocardial Bridging in Left Anterior Descending Coronary Arteries
ELSEVIER SCIENCE INC. 2014: B104
View details for DOI 10.1016/j.jacc.2014.07.406
View details for Web of Science ID 000359649700354
-
Benefits and Barriers to Cardiac Rehabilitation
LIPPINCOTT WILLIAMS & WILKINS. 2014: 399-400
View details for Web of Science ID 000341496000043
-
Commentary on late breaking trials in interventional cardiology at ESC, VIVA, TCT, AHA (Fall 2012), and ACC 2013
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
2014; 83 (6): 936-943
Abstract
With the plethora of clinical trials, it is difficult for busy interventional cardiologists to stay up to date. Therefore, the Society for Cardiovascular Angiography and Interventions (SCAI) publications committee concisely summarized and provided editorial commentary on the most important trials from recent, large international meetings. The intent is to provide this summary every six months to allow quick assimilation of trial results into interventional practice.
View details for DOI 10.1002/ccd.25301
View details for Web of Science ID 000334797900024
View details for PubMedID 24273219
-
DIAGNOSTIC ACCURACY OF MRI ASSESSMENT OF CORONARY ENDOTHELIAL FUNCTION COMPARED WITH INVASIVE ANGIOGRAPHY
ELSEVIER SCIENCE INC. 2014: A1255
View details for DOI 10.1016/S0735-1097(14)61255-9
View details for Web of Science ID 000359579102013
-
CORONARY PHYSIOLOGICAL INDICES IN PATIENTS WITH MYOCARDIAL BRIDGING
ELSEVIER SCIENCE INC. 2014: A1691
View details for DOI 10.1016/S0735-1097(14)61694-6
View details for Web of Science ID 000359579102449
-
MINDFULNESS BASED STRESS REDUCTION FOR PATIENTS REFERRED TO CARDIOVASCULAR REHABILITATION
SPRINGER. 2014: S257
View details for Web of Science ID 000334408301235
-
Best Practices for Transradial Angiography and Intervention: A Consensus Statement From the Society for Cardiovascular Angiography and Intervention's Transradial Working Group
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
2014; 83 (2): 228-236
View details for DOI 10.1002/ccd.25209
View details for Web of Science ID 000329847600014
-
Invasive Evaluation of Chest Pain in Patients With Angiographically Normal Coronary Arteries
LIPPINCOTT WILLIAMS & WILKINS. 2013
View details for Web of Science ID 000332162908129
-
Impact of Myocardial Bridging on Coronary Endothelial Dysfunction and Atherosclerotic Plaque Formation
LIPPINCOTT WILLIAMS & WILKINS. 2013
View details for Web of Science ID 000332162906321
-
It is Time for Sex Inequality in Patients with ST-elevation Myocardial Infarction.
Catheterization and cardiovascular interventions
2013; 82 (1): 27-28
View details for DOI 10.1002/ccd.25026
View details for PubMedID 23788384
-
Can we bear another bare-metal stent study?
Catheterization and cardiovascular interventions
2013; 81 (7): 1095-1096
View details for DOI 10.1002/ccd.24964
View details for PubMedID 23704063
-
A novel stress echocardiography pattern for myocardial bridge with invasive structural and hemodynamic correlation.
Journal of the American Heart Association
2013; 2 (2)
Abstract
Patients with a myocardial bridge (MB) and no significant obstructive coronary artery disease (CAD) may experience angina presumably from ischemia, but noninvasive assessment has been limited and the underlying mechanism poorly understood. This study seeks to correlate a novel exercise echocardiography (EE) finding for MBs with invasive structural and hemodynamic measurements.Eighteen patients with angina and an EE pattern of focal end-systolic to early-diastolic buckling in the septum with apical sparing were prospectively enrolled for invasive assessment. This included coronary angiography, left anterior descending artery (LAD) intravascular ultrasound (IVUS), and intracoronary pressure and Doppler measurements at rest and during dobutamine stress. All patients were found to have an LAD MB on IVUS. The ratios of diastolic intracoronary pressure divided by aortic pressure at rest (Pd/Pa) and during dobutamine stress (diastolic fractional flow reserve [dFFR]) and peak Doppler flow velocity recordings at rest and with stress were successfully performed in 14 patients. All had abnormal dFFR (≤0.75) at stress within the bridge, distally or in both positions, and on average showed a more than doubling in peak Doppler flow velocity inside the MB at stress. Seventy-five percent of patients had normalization of dFFR distal to the MB, with partial pressure recovery and a decrease in peak Doppler flow velocity.A distinctive septal wall motion abnormality with apical sparing on EE is associated with a documented MB by IVUS and a decreased dFFR. We posit that the septal wall motion abnormality on EE is due to dynamic ischemia local to the compressed segment of the LAD from the increase in velocity and decrease in perfusion pressure, consistent with the Venturi effect.
View details for DOI 10.1161/JAHA.113.000097
View details for PubMedID 23591827
-
A novel stress echocardiography pattern for myocardial bridge with invasive structural and hemodynamic correlation.
Journal of the American Heart Association
2013; 2 (2)
View details for DOI 10.1161/JAHA.113.000097
View details for PubMedID 23591827
-
COGNITIVE BEHAVIORAL THERAPY FOR INSOMNIA IN WOMEN WITH CARDIOVASCULAR DISEASE
SPRINGER. 2013: S268
View details for Web of Science ID 000209928002026
-
Myocardial Bridging: Novel Insights from Exercise Echocardiographic Correlations with Hemodynamic Measurements - The Venturi Effect
LIPPINCOTT WILLIAMS & WILKINS. 2012
View details for Web of Science ID 000208885004331
-
The Impact of Sex Differences on Fractional Flow Reserve-Guided Percutaneous Coronary Intervention A FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) Substudy
JACC-CARDIOVASCULAR INTERVENTIONS
2012; 5 (10): 1037-1042
Abstract
This study sought to evaluate the impact of sex differences on fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI).The FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study demonstrated that FFR-guided PCI improves outcomes compared with an angiography-guided strategy. The role of FFR-guided PCI in women versus men has not been evaluated.We analyzed 2-year data from the FAME study in the 744 men and 261 women with multivessel coronary disease, who were randomized to angiography- or FFR-guided PCI. Statistical comparisons based on sex were stratified by treatment method.Although women were older and had significantly higher rates of hypertension than men did, there were no differences in the rates of major adverse cardiac events (20.3% vs. 20.2%, p = 0.923) and its individual components at 2 years. FFR values were significantly higher in women than in men (0.75 ± 0.18 vs. 0.71 ± 0.17, p = 0.001). The proportion of functionally significant lesions (FFR ≤ 0.80) was lower in women than in men for lesions with 50% to 70% stenosis (21.1% vs. 39.5%, p < 0.001) and for lesions with 70% to 90% stenosis (71.9% vs. 82.0%, p = 0.019). An FFR-guided strategy resulted in similar relative risk reductions for death, myocardial infarction, and repeat revascularization in men and in women. There were no interactions between sex and treatment method for any outcome variables.In comparison with men, angiographic lesions of similar severity are less likely to be ischemia-producing in women. An FFR-guided PCI strategy is equally beneficial in women as it is in men.
View details for DOI 10.1016/j.jcin.2012.06.016
View details for PubMedID 23078733
-
Second-Place Winner: Anxiety, Depression, and Coping Strategies in Patients Presenting to a Women's Heart Health Clinic
LIPPINCOTT WILLIAMS & WILKINS. 2012: 289–89
View details for Web of Science ID 000305337500007
-
Most accurate definition of a high femoral artery puncture: Aiming to better predict retroperitoneal hematoma in percutaneous coronary intervention
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
2012; 80 (1): 37-42
Abstract
Retroperitoneal hematoma (RPH) increases morbidity and mortality in percutaneous coronary intervention (PCI). High femoral arteriotomy is an independent predictor of RPH, but the optimal angiographic criterion for defining a high puncture is unknown.We retrospectively identified 557 consecutive PCI cases with femoral angiograms. Arteriotomy sites were categorized as high based on three angiographic criteria: at or above the proximal third of the femoral head (criterion A), at or above the most inferior border of the inferior epigastric artery (criterion B), and at or above the origin of the inferior epigastric artery (criterion C). Cases of RPH were then identified.Of the 557 PCI patients, 26 had a high femoral arteriotomy by criterion A, 17 by criterion B, and 6 by criterion C. Among these patients with a high arteriotomy, RPH occurred in four with criterion A, in three with criterion B, and in one with criterion C. Of the three criteria, criterion A most strongly correlated with RPH (odds ratio [OR] 96, 95% confidence interval [CI] 10.3-898.4; p < 0.0001) compared with criterion B (OR 58, 95% CI 8.9 to 372.6; p < 0.0001) or C (OR 27, 95% CI 2.6 to 290.1; p = 0.053). All criteria had high specificity (A, 96%; B, 97%; C, 99%), but the sensitivity was higher with criterion A (80%) than criterion B (60%) or C (20%), and statistically, the use of criterion A led to the most accurate risk-stratification for RPH (A, κ = 0.79; B, κ = 0.59; C, κ = 0.19).Among the three common definitions of high arteriotomy, femoral artery puncture at or above the proximal third of the femoral head is the landmark that most accurately risk stratifies PCI patients for development of RPH.
View details for DOI 10.1002/ccd.23175
View details for PubMedID 22511409
-
PATIENTS' PREFERENCES FOR INTEGRATING MENTAL HEALTH SERVICES IN A WOMEN'S HEART HEALTH CLINIC
SPRINGER. 2012: S98–S98
View details for Web of Science ID 000302092400379
-
CTO PCI USING DEVICE BASED ANTEGRADE DISSECTION AND RE-ENTRY: IMPROVING SUCCESS FOR ALL COMERS
61st Annual Scientific Session and Expo of the American-College-of-Cardiology (ACC)/Conference on ACC-i2 with TCT
ELSEVIER SCIENCE INC. 2012: E105–E105
View details for Web of Science ID 000302326700106
-
THE IMPACT OF SEX DIFFERENCES ON FRACTIONAL FLOW RESERVE-GUIDED PERCUTANEOUS CORONARY INTERVENTION: A FAME SUBSTUDY
ELSEVIER SCIENCE INC. 2012: E305
View details for DOI 10.1016/S0735-1097(12)60306-4
View details for Web of Science ID 000302326700306
-
Comparison of the Frequency of Coronary Artery Disease in Alcohol-Related Versus Non-Alcohol-Related Endstage Liver Disease
AMERICAN JOURNAL OF CARDIOLOGY
2011; 108 (11): 1552-1555
Abstract
There are conflicting data as to the prevalence of coronary artery disease (CAD) in patients with end-stage liver disease (ESLD) being assessed for liver transplantation (LT). The aims of this study were to compare the prevalence of CAD in patients with alcohol-related versus non-alcohol-related ESLD and to assess the diagnostic utility of dobutamine stress echocardiography (DSE) in predicting angiographically important CAD. Consecutive patients with ESLD being assessed for LT (n = 420, mean age 56 ± 8 years) were identified and divided into groups of those with alcohol-related ESLD (n = 125) and non-alcohol-related ESLD (n = 295). Demographic characteristics, CAD risk factors, results of DSE, and coronary angiographic characteristics were recorded. There were no significant differences in age or CAD risk factors between groups. The incidence of severe CAD (>70% diameter stenosis) was 2% in the alcohol-related ESLD group and 13% in the non-alcohol-related ESLD group (p <0.005). In the 2 groups, the presence of ≥1 CAD risk factor was associated with significant CAD (p <0.05 for all). Absence of cardiac risk factors was highly predictive in ruling out angiographically significant disease (negative predictive value 100% for alcohol-related ESLD and 97% for non-alcohol-related ESLD). DSE was performed in 205 patients. In the 2 groups, DSE had poor predictive value for diagnosing significant CAD but was useful in ruling out patients without significant disease (negative predictive value 89% for alcohol-related ESLD and 80% for non-alcohol-related ESLD). In conclusion, there was a significantly lower prevalence of severe CAD in patients with alcohol-related ESLD. These findings suggest that invasive coronary angiography may not be necessary in this subgroup, particularly in the absence of CAD risk factors and negative results on DSE.
View details for DOI 10.1016/j.amjcard.2011.07.013
View details for PubMedID 21890080
-
Quantitative Comparison of Microcirculatory Dysfunction in Patients With Stress Cardiomyopathy and ST-Segment Elevation Myocardial Infarction
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
2011; 58 (23): 2430-2431
View details for DOI 10.1016/j.jacc.2011.08.046
View details for Web of Science ID 000297319700016
View details for PubMedID 22115653
-
Sex Differences in Neointimal Hyperplasia Following Zotarolimus-Eluting Stent Implantation: Potential Impact of Drug and Carrier Matrix
Scientific Sessions of the American-Heart-Association/Resuscitation Science Symposium
LIPPINCOTT WILLIAMS & WILKINS. 2011
View details for Web of Science ID 000299738704188
-
Transradial arterial access for coronary and peripheral procedures: Executive summary by the transradial committee of the SCAI
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
2011; 78 (6): 823-839
Abstract
In response to growing U.S. interest, the Society for Coronary Angiography and Interventions recently formed a Transradial Committee whose purpose is to examine the utility, utilization, and training considerations related to transradial access for percutaneous coronary and peripheral procedures. With international partnership, the committee has composed a comprehensive overview of this subject presented here-with.
View details for DOI 10.1002/ccd.23052
View details for Web of Science ID 000297111100001
View details for PubMedID 21544927
-
Do Not Be Deceived by the Cunning Jailed Side Branch
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
2011; 78 (5): 727-728
View details for DOI 10.1002/ccd.23384
View details for Web of Science ID 000296412800013
View details for PubMedID 22025473
-
Sex Differences in Neointimal Hyperplasia Following Endeavor Zotarolimus-Eluting Stent Implantation
AMERICAN JOURNAL OF CARDIOLOGY
2011; 108 (7): 912-917
Abstract
Inconsistent results in outcomes have been observed between the genders after drug-eluting stent implantation. The aim of this study was to investigate gender differences in neointimal proliferation for the Endeavor zotarolimus-eluting stent (ZES) and the Driver bare-metal stent (BMS). A total of 476 (n = 391 ZES, n = 85 BMS) patients whose volumetric intravascular ultrasound analyses were available at 8-month follow-up were studied. At 8 months, neointimal obstruction and maximum cross-sectional narrowing (CSN) were significantly lower in women than in men receiving ZES (neointimal obstruction 15.5 ± 9.5% vs 18.2 ± 10.9%, p = 0.025; maximum CSN 30.3 ± 13.2% vs 34.8 ± 15.0%, p = 0.007). Conversely, these parameters tended to be higher in women than in men receiving BMS (neointimal obstruction 36.3 ± 15.9% vs 27.5 ± 17.2%, p = 0.053; maximum CSN 54.3 ± 18.6% vs 45.6 ± 18.3%, p = 0.080). There was a significant interaction between stent type and gender regarding neointimal obstruction (p = 0.001) and maximum CSN (p = 0.003). Multivariate linear regression analysis revealed that female gender was independently associated with lower neointimal obstruction (p = 0.027) and maximum CSN (p = 0.004) for ZES but not for BMS. Compared to BMS, ZES were independently associated with a reduced risk for binary restenosis in both genders (odds ratio for women 0.003, p = 0.001; odds ratio for men 0.191, p <0.001), but the magnitude of this risk reduction with ZES was significantly greater in women than men (p = 0.015). In conclusion, female gender is independently associated with decreased neointimal hyperplasia in patients treated with ZES. The magnitude of risk reduction for binary restenosis with ZES is significantly greater in women than in men.
View details for DOI 10.1016/j.amjcard.2011.05.019
View details for Web of Science ID 000295863200002
View details for PubMedID 21784390
-
Comparison of Drug-Eluting Versus Bare Metal Stents in Cardiac Allograft Vasculopathy
AMERICAN JOURNAL OF CARDIOLOGY
2011; 108 (5): 665-668
Abstract
Although not a definitive treatment, percutaneous coronary intervention offers a palliative benefit to patients with cardiac allograft vasculopathy. Given the superior outcomes with drug-eluting stents (DESs) over bare metal stents (BMSs) in native coronary artery disease, similar improvements might be expected in transplant patients; however, the results have been mixed. Consecutive cardiac transplantation recipients at a single center receiving a stent for de novo cardiac allograft vasculopathy from 1997 to 2009 were retrospectively analyzed according to receipt of a DES versus a BMS. The angiographic and clinical outcomes were subsequently evaluated at 1 year. The baseline clinical and procedural characteristics were similar among those receiving DESs (n = 18) and BMSs (n = 16). Quantitative coronary angiography revealed no difference in the reference diameter, lesion length, or pre-/postprocedural minimal luminal diameter. At the 12-month angiographic follow-up visit, the mean lumen loss was significantly lower in the DES group than in the BMS group (0.19 ± 0.73 mm vs 0.76 ± 0.97 mm, p = 0.02). The DES group also had a lower rate of in-stent restenosis (12.5% vs 33%, p = 0.18), as well as a significantly lower rate of target lesion revascularization (0% vs 19%, p = 0.03). At 1 year, DESs were associated with a lower composite rate of cardiac death and nonfatal myocardial infarction (12% vs 38%, p = 0.04). In conclusion, DESs are safe and effective in the suppression of neointimal hyperplasia after percutaneous coronary intervention for cardiac allograft vasculopathy, resulting in significantly lower rates of late lumen loss and target lesion revascularization, as well as a reduced combined rate of cardiac death and nonfatal myocardial infarction.
View details for DOI 10.1016/j.amjcard.2011.04.014
View details for PubMedID 21684511
-
Stress-induced cardiomyopathy associated with a transfusion reaction: A case of potential crosstalk between the histaminic and adrenergic systems
EXPERIMENTAL & CLINICAL CARDIOLOGY
2011; 16 (1): 30-32
Abstract
The adrenergic and histaminergic systems have been reported to have analogous effects on the heart. A case of transient ventricular dysfunction with echocardiographic findings characteristic of stress-induced cardiomyopathy (also known as takotsubo cardiomyopathy) in a patient who had an urticarial transfusion reaction is described. The effect of histamine on ventricular function and its interaction with the adrenergic system are discussed.
View details for Web of Science ID 000300518800008
View details for PubMedID 21523205
View details for PubMedCentralID PMC3076164
-
Images in intervention. Intramural hematoma appearing as a new lesion after coronary stenting.
JACC. Cardiovascular interventions
2011; 4 (1): 129-130
View details for DOI 10.1016/j.jcin.2010.07.019
View details for PubMedID 21251640
-
Intramural Hematoma Appearing as a New Lesion After Coronary Stenting
JACC-CARDIOVASCULAR INTERVENTIONS
2011; 4 (1): 129-130
View details for DOI 10.1016/j.jcin.2010.07.019
View details for Web of Science ID 000287181500018
-
Alcohol-Related Cirrhosis is Associated with Significantly Less Angiographically Severe Disease than Non-Alcoholic Related Cirrhosis
ELSEVIER SCIENCE INC. 2010: B42
View details for Web of Science ID 000209824200180
-
A Big Man With a Broken Heart: Stress-Induced Cardiomyopathy in a Morbidly Obese Man
MAYO CLINIC PROCEEDINGS
2010; 85 (9): 864-865
View details for DOI 10.4065/mcp.2010.0276
View details for Web of Science ID 000281387500012
View details for PubMedID 20810798
View details for PubMedCentralID PMC2931624
-
Greater Negative Emotional Profiles in Young Women Compared to Young Men Following Coronary Heart Disease Diagnosis
LIPPINCOTT WILLIAMS & WILKINS. 2009: S459-S460
View details for Web of Science ID 000271831500637
-
Safety and Efficacy of Drug Eluting Stents for Treatment of Cardiac Allograft Vasculopathy: A Prospective Clinical and Angiographic Study
21st Annual Transcatheter Cardiovascular Therapeutics Conference
EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC. 2009: 138D–138D
View details for Web of Science ID 000269981600385
-
Launching a successful transradial program.
journal of invasive cardiology
2009; 21 (8): 3A-10A
Abstract
There is an increasing interest in performing transradial (TR) procedures in the United States, but with so few experienced operators, developing a TR program often means figuring out a lot on one's own. Certain necessary fundamentals - including a good reason for doing procedures transradially, getting adequate training, gaining the support of cath lab staff, using the right equipment, and having patience and perseverance through learning and change - improve the chances of success. In discussing each of these fundamentals, this article reviews the advantages of a radial approach compared with a femoral approach; describes ways to acquire TR training; stresses the importance of involving nurses, technicians, administrators, and colleagues in the process; encourages the use of designated radial equipment for enhancing success; and demonstrates the learning curve by describing a single operator experience during the first year of launching a TR program.
View details for PubMedID 19734568
-
Predictive value of the index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
2008; 51 (5): 560-565
Abstract
The objective of this study is to evaluate the predictive value of the index of microcirculatory resistance (IMR) in patients undergoing primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI).Despite adequate epicardial artery reperfusion, a number of patients with STEMI have a poor prognosis because of microvascular damage. Assessing the status of the microvasculature in this setting remains challenging.In 29 patients after primary PCI for STEMI, IMR was measured with a pressure sensor/thermistor-tipped guidewire. The Thrombolysis In Myocardial Infarction (TIMI) myocardial perfusion grade, TIMI frame count, coronary flow reserve, and ST-segment resolution were also recorded.The IMR correlated significantly with the peak creatinine kinase (CK) (R = 0.61, p = 0.0005) while the other measures of microvascular dysfunction did not. In patients with an IMR greater than the median value of 32 U, the peak CK was significantly higher compared with those having values
32 U compared with View details for DOI 10.1016/j.jacc.2007.08.062
View details for PubMedID 18237685
-
Femoral artery puncture above the proximal third of the femoral head better predicts retroperitoneal hemorrhage in percutaneous coronary intervention than arteriotomies above the most inferior border or origin of the inferior epigastric artery
19th Annual Transcatheter Cardiovascular Therapeutics Symposium
EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC. 2007: 228L–228L
View details for Web of Science ID 000250393900582
-
Ischemic heart disease in women: An appropriate time to discriminate
REVIEWS IN CARDIOVASCULAR MEDICINE
2007; 8 (2): 61-68
Abstract
Although cardiovascular mortality for men has been declining, the number of women dying from cardiovascular disease has slightly increased. Differences between women and men have been identified throughout the entire spectrum of ischemic heart disease, from risk factors to presentation and from diagnosis to treatment and outcomes. In the setting of an acute coronary syndrome or acute myocardial infarction, women are significantly more likely than men to report multiple non-chest pain symptoms, including dyspnea, nausea/vomiting, abdominal pain, back pain, neck pain, and jaw pain. Investigations into the pathophysiology of ischemic heart disease in women have broken away from the traditional thinking that coronary artery disease simply equals epicardial stenosis. In women, the new paradigm of coronary artery disease also focuses on diffuse atherosclerosis, endothelial dysfunction, and microvascular disease. Further research focusing on sex differences in cardiovascular disease is needed, but enough is currently known to offer a sex-based approach, which may ultimately lead to improved outcomes.
View details for Web of Science ID 000247793600003
View details for PubMedID 17603424
-
Index of microcirculatory resistance: A novel measure for predicting myocardial damage in patients with acute myocardial infarction
79th Annual Scientific Session of the American-Heart-Association
LIPPINCOTT WILLIAMS & WILKINS. 2006: 586–87
View details for Web of Science ID 000241792803637
-
Selective renal arterial infusion of fenoldopam for the prevention of contrast-induced nephropathy.
Journal of interventional cardiology
2006; 19 (1): 75-79
Abstract
Contrast-induced nephropathy (CIN) remains an important complication of angiographic procedures, particularly among patients with significant renal impairment. To date, vasodilator therapies such as fenoldopam have failed to prevent CIN, possibly because significant hypotension as a result of systemic infusion has limited the ability to deliver adequate drug levels to the renal vasculature. We present a case of averted CIN after multivessel coronary intervention in a diabetic patient with severe renal insufficiency, potentially due to bilateral renal arterial infusion of fenoldopam. Our subsequent experience with intrarenal fenoldopam in nine additional procedures in eight other high risk patients resulted in one case of asymptomatic transient CIN. Further studies are warranted to evaluate the efficacy of intrarenal administration of vasodilator therapies such as fenoldopam for the prevention of CIN.
View details for PubMedID 16483344
-
Is the obesity paradox for real? The effect of body mass index an mortality following percutaneous coronary intervention for those presenting with an ST elevation myocardial infarction
LIPPINCOTT WILLIAMS & WILKINS. 2005: U759
View details for Web of Science ID 000232956404557
-
Risk factors for the development of retroperitoneal hematoma after percutaneous coronary intervention in the era of glycoprotein IIb/IIIa inhibitors and vascular closure devices
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
2005; 45 (3): 363-368
Abstract
We sought to determine the incidence, clinical features, and risk factors for retroperitoneal hematoma (RPH) after percutaneous coronary intervention (PCI).Little is known about the clinical features, outcomes, and determinants of this serious complication in the contemporary era of PCI.A retrospective analysis yielded 26 cases of RPH out of 3,508 consecutive patients undergoing PCI between January 2000 and January 2004. Cases were compared with a randomly selected sample of 50 control subjects without RPH.The incidence of RPH was 0.74%. Features of RPH included abdominal pain (42%), groin pain (46%), back pain (23%), diaphoresis (58%), bradycardia (31%), and hypotension (92%). The mean systolic blood pressure nadir was 75 mm Hg. The hematocrit dropped by 11.5 +/- 5.1 points from baseline in RPH patients, as compared with 2.3 +/- 3.3 points in controls (p < 0.0001). The mean hospital stay was longer in RPH patients (2.9 +/- 3.8 days vs. 1.7 +/- 1.5 days, p = 0.06). The following variables were found to be independent predictors of RPH: female gender (odds ratio [OR] 5.4, p = 0.005), low body surface area (BSA <1.73 m(2); OR 7.1, p = 0.008), and higher femoral artery puncture (OR 5.3, p = 0.013). There was no association between RPH and arterial sheath size, use of glycoprotein IIb/IIIa inhibitors, or deployment of a vascular closure device.Female gender, low BSA, and higher femoral artery puncture are significant risk factors for RPH. Awareness of the determinants and clinical features of RPH may aid in prevention, early recognition, and prompt treatment.
View details for DOI 10.1016/j.jacc.2004.10.042
View details for PubMedID 15680713
- Is the obesity paradox for real? The effect of body mass index on mortality following percutaneous coronary intervention for those presenting with an ST elevation myocardial infarction. Circulation 2005; 112 ((17, supp)): II-695
- The influence of body mass index on mortality following percutaneous coronary intervention in those presenting with unstable angina or non-ST elevation myocardial infarction: is there an obesity paradox? Am J Cardiol 2005; 96 (7,supp1): 106H
-
"Tako-tsubo-like left ventricular dysfunction": a clinical entity mimicking acute myocardial infarction with a favorable prognosis.
American journal of geriatric cardiology
2004; 13 (6): 323-326
Abstract
An emotionally-distressed, elderly Caucasian woman presented with chest pain and hypertension. Electrocardiogram showed inferior ST-segment elevation, and an urgent cardiac catheterization was performed. Coronary angiography revealed normal appearing coronary arteries; however, left ventriculography showed extensive left ventricular apical akinesis. The patient had a mild rise in cardiac enzyme levels indicative of myocardial injury. She was discharged after an uncomplicated in-hospital course. One month later, the left ventricular wall motion abnormality had improved. In this report, the authors discuss this compilation of findings known as tako-tsubo-like left ventricular dysfunction.
View details for PubMedID 15538070
-
Women remain at higher risk for retroperitoneal hematoma after percutaneous coronary intervention in the era of glycoprotein IIb/IIIa inhibitors and vascular closure devices
53rd Annual Scientific Session of the American-College-of-Cardiology
ELSEVIER SCIENCE INC. 2004: 63A–63A
View details for Web of Science ID 000189388500266
-
Direct-to-consumer advertisements for prescription drugs: what are Americans being sold?
LANCET
2001; 358 (9288): 1141-1146
Abstract
Pharmaceutical companies spent US$1.8 billion on direct-to-consumer advertisements for prescription drugs in 1999. Our aim was to establish what messages are being communicated to the public by these advertisements.We investigated the content of advertisements, which appeared in ten magazines in the USA. We examined seven issues of each of these published between July, 1998, and July, 1999.67 advertisements appeared a total of 211 times during our study. Of these, 133 (63%) were for drugs to ameliorate symptoms, 54 (26%) to treat disease, and 23 (11%) to prevent illness. In the 67 unique advertisements, promotional techniques used included emotional appeals (45, 67%) and encouragement of consumers to consider medical causes for their experiences (26, 39%). More advertisements described the benefit of medication with vague, qualitative terms (58, 87%), than with data (9, 13%). However, half the advertisements used data to describe side-effects, typically with lists of side-effects that generally occurred infrequently. None mentioned cost.Provision of complete information about the benefit of prescription drugs in advertisements would serve the interests of physicians and the public.
View details for Web of Science ID 000171399000011
View details for PubMedID 11597668